fluorouracil has been researched along with Recrudescence in 349 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 59 (16.91) | 18.7374 |
| 1990's | 52 (14.90) | 18.2507 |
| 2000's | 83 (23.78) | 29.6817 |
| 2010's | 142 (40.69) | 24.3611 |
| 2020's | 13 (3.72) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, A; Ii, Y; Irie, T; Kawaguchi, M; Kawai, M; Kobari, A; Kojima, Y; Momose, H; Sakamoto, K; Sugimoto, K; Terao, Y; Tomiki, Y; Tsukamoto, R | 1 |
| Coroneo, MT; Francis, IC; Lee, BWH; Sidhu, AS | 1 |
| Dong, G; Hu, J; Jin, Q; Liu, Y; Qu, C; Wang, L; Wang, M; Wu, H | 1 |
| Aravantinos, G; Dessypris, N; Gkoura, S; Karampinos, K; Mauri, D; Miaris, N; Samantas, E; Sgouros, J; Spathas, N; Stamoulis, G; Theodoropoulos, I; Tzoudas, F; Visvikis, A | 1 |
| Alonso, V; Capdevila, J; Feliu Batlle, J; Fernandez-Martos, C; Gallego, J; García-Albéniz, X; García-Carbonero, R; Heredia-Soto, V; Layos, L; Losa, F; Machado, I; Maurel, J; Montagut, C; Nogué, M; Pericay, C; Pesántez, D; Rodríguez-Salas, N; Salud, A; Ten Hoorn, S; Vera, R; Vermeulen, L; Viñal, D | 1 |
| Chen, X; Chen, Y; Guo, F; Han, G; Li, W; Ma, L; Pan, L; Shu, Y; Tang, J; Tian, Y; Xie, L; Xu, H; Zhang, J; Zhang, X | 1 |
| Neill, BC; Seger, EW; Tarantino, IS; Wang, T | 1 |
| Ebrahim, HM; Ghonemy, S; Ibrahim Ali, M | 1 |
| Baker, C; MacMahon, B; Sinclair, R; Spelman, L; Supranowicz, M | 1 |
| Bradley, G; Caminiti, MF; El-Rabbany, M; Jeon, J | 1 |
| Ekstein, SF; Meves, A; Moran, SL; Wyles, SP | 1 |
| Deng, K; Liu, X; Liu, Y; Ogawa, R; Xiao, H; Xu, X | 1 |
| Khattab, FM; Samir, MA | 1 |
| Ailawadhi, S; Arthurs, JR; Fischer, DL; Gannon, NA; Gibbs, M; Gupta, E; Irvin, M; Kakar, TS; Waddle, M | 1 |
| Fukui, Y; Hanaoka, Y; Kuroyanagi, H; Matoba, S; Tate, T; Toda, S; Tomizawa, K | 1 |
| Arruda, GV; Fonseca, EC; Rocha, EM | 1 |
| Boto de Los Bueis, A; García Tirado, A; Rivas Jara, L | 1 |
| Fukunaga, M; Honda, S; Kobayashi, K; Konishi, K; Miki, H; Okada, K; Okamoto, A; Ota, H; Saito, A; Tokuyama, S; Yokoyama, S; Yukimoto, R | 1 |
| Adams, R; Downing, A; Gilbert, DC; Glynne-Jones, R; Harrison, M; Hawkins, M; Jones, CM; Muirhead, R; Sebag-Montefiore, D | 1 |
| Kodama, M; Kondo, S; Miyahara, Y; Yamazaki, K; Yokoyama, M; Yoshida, A | 1 |
| Gu, D; Liu, B; Song, R; Xie, J; Yu, B; Zhang, L; Zhang, X | 1 |
| Georgiou, D; Hutson, RC; Laios, A; Thangavelu, A; Theophilou, G; Tranoulis, A | 1 |
| Chung, MJ; Jang, HS; Jeong, JU; Jeong, S; Kim, SH; Lee, JH; Nam, TK; Song, JH; Yu, M | 1 |
| Ahmad, S; Khalid, FA; Mehrose, MY; Mujahid, AM; Rehman, SU; Saleem, M; Tarar, MN; Yousaf, MA | 1 |
| Chong, T; Costa, C; Karimpour-Fard, A; LaRanger, R; Mathes, D; Wright, WE | 1 |
| Meneghim, RLFS; Natsuaki, KL; Oliveira, AC; Padovani, CR; Satto, LH; Schellini, SA; Viveiros, MMH | 1 |
| Hamada, T; Ohashi, S; Ohta, K; Taniguchi, E; Yamagami, Y; Yoshikawa, M | 1 |
| Chen, CW; Cheng, TL; Hu, HM; Lin, SR; Lu, CY; Tsai, HL; Uen, YH; Wang, JY | 1 |
| Barker, C; Lee, L; Mais, K; McPartlin, AJ; Mitchell, K; Slevin, NJ; Swindell, R; Sykes, A; Yap, B | 1 |
| Ahn, JS; Jeon, JR; Paik, SW; Park, CK; Park, TK; Sinn, DH; Yoo, HS | 1 |
| Asao, Y; Fuji, H; Furuyama, H; Kadokawa, Y; Kondo, M; Machimoto, T; Nishigori, T; Okumura, S; Yoshimura, T | 1 |
| Arisawa, Y; Chiba, N; Hashimoto, M; Ishii, M; Ishikawa, S; Nakamura, T; Shimada, A | 1 |
| Hashimoto, Y; Kawachi, Y; Kawahara, M; Kitami, C; Makino, S; Nikkuni, K; Nishimura, A; Okamura, T | 1 |
| Ezaki, T; Iguchi, T; Ito, S; Koga, T; Nozoe, E; Nozoe, T; Ohga, T | 1 |
| Bielicki, D; Binczak-Kuleta, A; Ciechanowicz, A; Drozdzik, M; Gołębiewska, M; Kaczmarczyk, M; Machoy-Mokrzynska, A; Pioch, W; Sulzyc-Bielicka, V | 1 |
| Chen, WW; Cheng, AL; Hsu, CH; Huang, TC; Lin, CC; Yeh, KH | 1 |
| Aitchison, M; Bray, CA; Graham, J; Innes, C; McMahon, L; Sylvester, R; Van Poppel, H; Vasey, PA | 1 |
| Dasanu, CA; Joseph, R | 1 |
| Bodh, SA; Goel, R; Kamal, S; Kumar, S | 1 |
| Barzi, A; Lenz, HJ; Sadeghi, S; Senagore, A; Shabihkhani, M; Thara, E; Yang, D; Yu, S | 1 |
| Cai, S; Li, W; Sun, M; Yu, Q; Zhang, W; Zhang, Z; Zhao, J; Zhu, D | 1 |
| Kita, I; Mukubo, H; Nakanuma, S; Sato, N; Yasui, T | 1 |
| Hasegawa, H; Kitagawa, Y; Kitasato, K; Murai, S; Nakadai, J; Oto, I; Shimizu, H; Yabe, N; Yoshikawa, T | 1 |
| Amagasa, H; Ami, K; Ando, M; Arai, K; Fujiya, K; Fukuda, A; Ganno, H; Gokita, K; Imai, K; Kamikozuru, H; Kawai, Y; Nagahama, T; Okada, Y; Seki, R; Takasaki, J; Takeuchi, S; Tei, S | 1 |
| Kita, I; Mukubo, H; Nakanuma, S; Sato, N; Takanaka, T; Yasui, T | 1 |
| Baba, H; Iida, S; Ishiguro, M; Ishikawa, T; Iwata, N; Kobayashi, H; Masuda, D; Matsuyama, T; Okazaki, S; Sugihara, K; Takahashi, H; Uetake, H | 1 |
| Asaka, S; Katsube, T; Kohno, T; Miyaki, A; Miyazawa, M; Murayama, M; Naritaka, Y; Shimakawa, T; Shimazaki, A; Shiozawa, S; Usuda, A; Yamaguchi, K; Yokomizo, H; Yoshimatsu, K | 1 |
| Hagino, S; Iwata, K; Kiriyama, M; Kurata, T; Makita, N; Tsuneda, A | 1 |
| Doi, T; Hoshi, M; Iijima, S; Ikeda, K; Kikkawa, N; Kurokawa, E; Makari, Y; Oshima, S | 1 |
| Iwanaga, T; Iwasaki, Y; Karasawa, K; Kawasaki, K; Maeda, Y; Oohinata, R; Yajima, K; Yuu, K | 1 |
| Chang, ZW; Dong, L; Han, ZF; Li, J; Lou, XP; Lu, P; Miao, JH | 1 |
| Fushimi, K; Takami, M; Tanabe, N | 1 |
| Kirii, Y; Miyamoto, M; Takagi, H | 1 |
| Altinyazar, HC; Işik, S; Koca, R; Sarici, G | 1 |
| Hirai, K; Igarashi, T; Miyamae, Y; Ogawa, H; Sunose, Y; Takahashi, K; Takahashi, N; Takeyoshi, I; Tanaka, K; Tsukagoshi, H; Yoshinari, D | 1 |
| Kigawa, G; Matsubara, T; Matsumiya, A; Mizukami, H; Nemoto, H; Saito, M; Tanaka, J; Tate, G; Umemoto, T | 1 |
| Aoe, K; Fujiwara, K; Gemba, K; Harita, S; Hosokawa, S; Hotta, K; Kanazawa, S; Kato, Y; Katsui, K; Kishino, D; Kiura, K; Kozuki, T; Kubo, T; Maeda, T; Nogami, N; Okada, T; Tabata, M; Takigawa, N; Tanimoto, M; Ueoka, H; Yasugi, M | 1 |
| Banerjee, S; Dyson, G; Farhana, L; Levi, E; Maddipati, KR; Majumdar, AP; Nangia-Makker, P; Patel, A; Rajendra, SG; Vasudevan, A; Woods, J; Yu, Y | 1 |
| Akasu, I; Fukushima, G; Kataoka, H; Kondo, K; Magata, H; Marutsuka, H; Nakamura, K; Otani, K; Sato, Y; Yano, K; Yonei, A | 1 |
| Dirschka, T; Dominicus, R; Karl, L; Rodríguez, R; Simon, JC; Willers, C | 1 |
| Iwasaki, W; Kichiraku, T; Kikkawa, M; Kotanagi, H; Kotanagi, K; Muto, O; Ouchi, S; Sato, K; Sawada, T | 1 |
| Kakizawa, N; Kato, T; Noda, H; Rikiyama, T; Toyama, N; Watanabe, F | 1 |
| Cho, JM; Go, SI; Jeon, KN; Kang, JH; Kang, MH; Kim, HG; Kim, MJ; Lee, A; Lee, GW; Lee, JH; Lee, US; Lee, WS | 1 |
| Hosoda, Y; Kim, Y; Nagai, K; Nishino, M; Okano, M; Tsujinaka, T; Yasui, M | 1 |
| Akita, H; Fujino, S; Fujiwara, Y; Fukata, T; Gotoh, K; Kishi, K; Marubashi, S; Miyoshi, N; Motoori, M; Noura, S; Ohue, M; Sakon, M; Sugimura, K; Takahashi, H; Yano, M | 1 |
| Doi, S; Kan, K; Maruyama, H; Murata, K; Nakaguchi, K; Nakano, K; Nushijima, Y; Okamura, S; Sugimoto, K | 1 |
| Egawa, T; Ito, Y; Kemmochi, T; Mihara, K; Nagashima, A; Nishiya, S; Yamashiro, N | 1 |
| Kemmett, D; Nasr, R; Smethurst, H; Thybo, S; Tolley, K | 1 |
| Boterberg, T; Ceelen, W; Pattyn, P; Thoen, H; Van Daele, E | 1 |
| Tahara, M; Yamazaki, T | 1 |
| Doki, Y; Hata, T; Hiraki, M; Mizushima, T; Mori, M; Nishimura, J; Nonaka, R; Ohtsuka, M; Takemasa, I; Takeyama, H; Uemura, M; Yamamoto, H | 1 |
| Fukuda, H; Iida, S; Iizuka, J; Ikeda, T; Kondo, T; Omae, K; Takagi, T; Tanabe, K; Toda, N | 1 |
| Arimitsu, H; Chibana, T; Hironaka, S; Ikeda, A; Ishige, F; Kainuma, O; Kobayashi, R; Nabeya, Y; Nagata, M; Saito, H; Soda, H; Takiguchi, N; Tonooka, T; Yamamoto, H; Yanagibashi, H | 1 |
| Arita, S; Fujii, T; Isaka, N; Koike, N; Ohshima, Y; Shinozaki, E; Takeuchi, T | 1 |
| Asanuma, K; Iai, A; Ichikawa, T; Inoue, T; Ishizu, H; Kaneko, S; Kishimoto, Y; Kuribara, T; Osa, K; Sano, T; Ueda, M | 1 |
| Cai, Z; Guan, H; Hong, C; Liang, Z; Luo, D; Luo, P; Tan, Z; Wei, Y; Yang, Z; Zeng, Z | 1 |
| Imanishi, T; Kakeji, Y; Kanaji, S; Kanemitsu, K; Nakamura, T; Okuno, T; Sumi, Y; Suzuki, S; Yamamoto, M; Yamashita, K | 1 |
| Hama, N; Hirao, M; Ikeda, M; Maeda, S; Miyake, M; Miyamoto, A; Miyazaki, M; Nakamori, S; Nishikawa, K; Sekimoto, M; Takeda, T; Tanaka, K; Uemura, M; Yamamoto, K | 1 |
| Hakamada, K; Miura, T; Nakayama, Y | 1 |
| Kitagawa, Y; Kitasato, K; Kunugi, C; Murai, S; Oto, I; Shimizu, H; Yabe, N; Yoshikawa, T | 1 |
| Hirakawa, K; Ikeya, T; Iseki, Y; Kimura, K; Kubo, N; Maeda, K; Muguruma, K; Nagahara, H; Ohira, G; Sakurai, K; Shibutani, M; Tamura, T; Tanaka, H; Toyokawa, T; Yamazoe, S | 1 |
| Amikura, K; Asayama, M; Fukuda, T; Ishikawa, H; Kawashima, Y; Kazama, S; Kurozumi, M; Mori, Y; Nishimura, Y; Nishizawa, Y; Sakamoto, H; Takano, M; Takenoya, T; Tanaka, Y | 1 |
| Goya, T; Hanaka, J; Kanamura, S; Nakayama, H; Takahashi, M; Takahashi, S; Wakamatsu, T | 1 |
| Hatano, Y; Ishibashi, M; Kato, K; Konda, R; Michishita, Y; Nozawa, T; Oyama, K; Sasaki, A | 1 |
| Bekibele, CO; Ogundipe, A; Olaniyan, S; Sarimiye, TF | 1 |
| Endo, T; Hasegawa, H; Ishii, Y; Kitagawa, Y; Kondo, T; Ochiai, H; Okabayashi, K; Shigeta, K; Tsuruta, M | 1 |
| Kanda, J; Muneoka, K; Sakata, J; Sasaki, M; Shirai, Y; Wakabayashi, H; Wakai, T | 1 |
| Amada, E; Baba, S; Kameyama, N; Mitsuhashi, H; Miyata, R; Tomita, M | 1 |
| Basit, I; Khan, MS; Malik, S | 1 |
| Endo, S; Kato, H; Katsube, T; Naritaka, Y; Okayama, S; Satake, M; Shimakawa, T; Shiozawa, S; Yamada, Y; Yano, Y; Yokomizo, H; Yoshimatsu, K | 1 |
| Dibbern, JL; Ghadban, T; Güngör, C; Izbicki, JR; Miro, JT; Reeh, M; Tsui, TY; Vashist, YK; Wellner, U | 1 |
| Fukunaga, M; Honda, S; Kobayashi, K; Konishi, K; Miki, H; Okada, K; Ota, H; Saito, A; Tokuyama, S; Yokoyama, S; Yoshioka, S; Yukimoto, R | 1 |
| Doki, Y; Haraguchi, N; Hata, T; Kudo, T; Matsuda, C; Mizushima, T; Mori, M; Nishimura, J; Ohara, N; Satoh, T; Takahashi, H; Yamamoto, H | 1 |
| Fujii, T; Funahashi, K; Kaneko, H; Kaneko, T; Katayanagi, T; Koda, T; Koike, J; Kurihara, A; Masuhara, H; Sawaguchi, Y; Shimada, H; Shiokawa, H; Suzuki, T; Ushigome, M; Watanabe, Y | 1 |
| Aizawa, M; Bamba, T; Homma, K; Katsumi, C; Matsuki, A; Nakagawa, S; Yabusaki, H | 1 |
| Ardavanis, A; Basioukas, S; Orphanos, G; Rigatos, G; Skafida, S | 1 |
| Guan, ZZ; Han, B; He, YJ; Li, YH; Lin, TY; Luo, HY; Qiu, MZ; Shi, YX; Wang, F; Xu, RH; Zhang, L | 1 |
| Kanekiyo, S; Katayama, S; Kitahara, M; Kubo, H; Tada, K | 1 |
| Abdelsalam, M; Ajarim, D; Alhusseiny, H; Amin, T; Bazarbashi, S; El-Bassiouni, M; Elweshi, A; Memon, M; Rehman, K; Soudy, H | 1 |
| Amonkar, MM; Cameron, D; Geyer, C; Sherrill, B; Stein, S; Walker, M | 1 |
| Boehlke, I; Bokemeyer, C; Budach, W; Hartmann, JT; Kollmannsberger, C; Oechsle, K; Stahl, M; Trarbach, T | 1 |
| Annecke, K; Busch, R; Harbeck, N; Hoefler, H; Kiechle, M; Klein-Hitpass, L; Kruse, E; Langer, R; Mages, J; Naehrig, J; Reich, U; Schmitt, M; Smida, J; Specht, K | 1 |
| Bardet, E; Benhamou, E; Bensadoun, RJ; Bourhis, J; Castaing, M; de Raucourt, D; Dolivet, G; Ferron, C; Géry, B; Grégoire, V; Hamoir, M; Janot, F; Julieron, M | 1 |
| Nishimura, T; Oka, M; Takeda, S; Tokunou, K; Yoshino, S | 1 |
| Becouarn, Y; Bedenne, L; Bouché, O; Bugat, R; Conroy, T; Douillard, JY; Ducreux, M; Gamelin, E; Gourgou-Bourgade, S; Kramar, A; Mineur, L; Raoul, JL; Seitz, JF; Viret, F; Ychou, M | 1 |
| Arai, H; Maruyama, H; Matsuda, A; Matsushita, A; Matsutani, T; Miyamoto, M; Nishi, Y; Sasajima, K; Sugiura, A; Suzuki, S; Tajiri, T; Wakabayashi, H; Yanagi, K; Yokoyama, T | 1 |
| Aoyama, T; Fujisawa, J; Masuda, M; Matsukawa, H; Rino, Y; Saeki, H | 1 |
| de Chaisemartin, C; Delpero, JR; Giovannini, M; Guiramand, J; Lelong, B; Moureau-Zabotto, L; Moutardier, V; Turrini, O; Viret, F | 1 |
| Ulrich, C | 1 |
| Chikuba, A; Chikuba, H; Matsuda, T; Nakamoto, M; Nezu, M; Shimamura, H; Suzuki, T; Takiue, T; Teraishi, F; Watanabe, T | 1 |
| Ciccocioppo, A; Hewett, PJ; Rieger, NA; Stephens, JH | 1 |
| Hartman-Adams, H; Juckett, G | 1 |
| Bowen, GM; Florell, SF; Hadley, JC; Hadley, ML; Tristani-Firouzi, P | 1 |
| Kato, S; Kawami, H; Nishigami, K; Yamaguchi, K; Yamaguchi, T | 1 |
| Chang, HM; Kang, HJ; Kang, YK; Kim, C; Kim, TW; Lee, JL; Lim, HY; Park, YS; Ryoo, BY; Ryu, MH | 1 |
| Albain, KS; Allred, DC; Baehner, FL; Barlow, WE; Bugarini, R; Davidson, NE; Gralow, JR; Hayes, DF; Hortobagyi, GN; Hudis, C; Ingle, JN; Livingston, RB; Osborne, CK; Perez, EA; Pritchard, KI; Ravdin, P; Shak, S; Shepherd, L; Sledge, GW; Winer, EP; Yeh, IT; Yoshizawa, C | 1 |
| Andre, F; Delaloge, S | 1 |
| Boku, N; Fukutomi, A; Hironaka, S; Kojima, T; Machida, N; Onozawa, Y; Sakamoto, T; Shimoyama, R; Taku, K; Todaka, A; Tomita, H; Tsushima, T; Yamazaki, K; Yasui, H | 1 |
| Jeong, HY; Kang, SH; Kim, JI; Kim, SH; Lee, BS; Moon, HS; Sung, JK | 1 |
| Barton, J; Burris, HA; Farley, C; Greco, FA; Hainsworth, JD; Macias-Perez, IM; Shipley, D; Spigel, DR | 1 |
| Fernández-Contreras, ME; Gamallo, C; García de Paredes, ML; Gisbert, JP; Guijarro, M; Hinojar-Gutiérrez, A; Rivas, N; Sánchez-Hernández, JJ | 1 |
| Cursiefen, C; Droutsas, K; Sekundo, W | 1 |
| Del Chiaro, M; Funel, N; Giaccone, G; Giovannetti, E; Hwang, JH; Kang, GH; Kim, MA; Kim, SW; Kim, YT; Leon, LG; Park, JK; Peters, GJ; Steinberg, SM; Voortman, J | 1 |
| Adachi, E; Hattori, M; Kato, N; Kawase, Y; Kuroiwa, M; Matsushita, H; Mizuno, A; Okochi, O; Sato, Y; Takami, Y; Takeda, S; Tsuboi, K | 1 |
| Aoyama, Y; Kaji, S; Kugimiya, M; Matsukawa, S; Matsuo, S; Shiratori, T | 1 |
| Baehner, FL; Baker, J; Clark-Langone, KM; Cowens, JW; Lavery, I; Lopatin, M; O'Connell, MJ; Paik, S; Shak, S; Watson, D; Wolmark, N; Yothers, G | 1 |
| Ahn, MJ; Do, IG; Ko, YH; Park, K; Park, YH; Won, YW | 1 |
| Arcangeli, G; Giannarelli, D; Giordano, C; Pinnarò, P; Rambone, R; Strigari, L | 1 |
| Chen, P; Cui, Y; Kong, D; Li, H; Li, Q; Ru, T; Song, T; Wu, Q; Zhang, T | 1 |
| Bergman, AM; Dalesio, O; Rinkes, IH; Schouten, SB; Snoeren, N; Tollenaar, RA; van der Sijp, JR; van Hillegersberg, R; Verheul, HM; Voest, EE | 1 |
| Fujitani, K; Hasegawa, H; Hirao, M; Kurokawa, Y; Mita, E; Nakazuru, S; Tsujinaka, T | 1 |
| Bang, YJ; Choe, KJ; Heo, DS; Im, SA; Kim, DW; Kim, JS; Kim, MA; Kim, NK; Kim, TM; Kim, TY; Kim, WH; Lee, KU; Lee, SH; Oh, DY; Yang, HK | 1 |
| Altinbas, M; Eroglu, C; Kaplan, B; Orhan, O; Ozkan, M; Soyuer, S; Ucar, K; Unal, D; Yildiz, OG | 1 |
| Hasegawa, Y; Kameyama, N; Kuboi, K; Matsumoto, N; Mitsuhashi, H; Sekimoto, Y; Tomita, M | 1 |
| Beaumont, C; Chambers, P; Gray, R; Handley, K; Hutchins, G; Kerr, D; Magill, L; Quirke, P; Richman, S; Seymour, M; Southward, K; Stahlschmidt, J | 1 |
| Ezaki, T; Iguchi, T; Kono, M; Maeda, T; Matsukuma, A; Mori, E; Nozoe, T | 1 |
| Abe, H; Gonda, K; Matsuo, S; Nakamura, I; Nishina, Y; Ohki, S; Shibata, M; Shimura, T; Takenoshita, S; Yajima, Y | 1 |
| Allegra, C; Foster, NR; Gallinger, S; Kim, GP; Labianca, R; Marsoni, S; Monges, G; Moore, MJ; Sargent, DJ; Sinicrope, FA; Thibodeau, SN; Yothers, G | 1 |
| Oyamatsu, M; Sakamoto, T; Sato, K; Shimada, Y; Tani, T | 1 |
| Doki, Y; Miyata, H; Mori, M; Motoori, M; Peng, YF; Shiozaki, H; Shiraishi, O; Tanaka, K; Yamasaki, M; Yano, M; Yasuda, T | 1 |
| Korovina, IaV; Nasyrov, AR; Pirtskhalava, TL | 1 |
| Hasegawa, J; Hirota, M; Kim, Y; Nezu, R; Nishimura, J; Yoshida, Y | 1 |
| Hamasu, S; Konishi, S; Manaka, D; Nishitai, R; Sakamoto, K; Uehara, M | 1 |
| Abe, T; Hatooka, S; Kondo, C; Mizota, A; Muro, K; Nomura, M; Shinoda, M; Shitara, K; Takahari, D; Ura, T; Yatabe, Y; Yokota, T | 1 |
| Goto, H; Hara, K; Higuchi, K; Hijioka, S; Kawai, H; Kondo, S; Mizuno, N; Nakamura, M; Niwa, Y; Ogura, T; Sawaki, A; Tajika, M; Yamao, K | 1 |
| Kanazawa, T; Kawai, K; Kazama, S; Kitayama, J; Mori, K; Nagawa, H; Nozawa, H; Saito, S; Sunami, E; Yazawa, K | 1 |
| Aström, G; Bergh, J; Brandberg, Y; Carlsson, L; Carstensen, J; Einbeigi, Z; Fernö, M; Hatschek, T; Hellström, M; Lidbrink, E; Linderholm, B; Lindh, B; Loman, N; Malmberg, M; Rotstein, S; Söderberg, M; Sundquist, M; Svensson, H; Walz, TM | 1 |
| Nishimura, Y; Sakamoto, H; Tanaka, Y; Yamaguchi, K; Yatsuoka, T | 1 |
| Haga, N; Ishibashi, K; Ishida, H; Kumamoto, K; Okada, N; Ono, T | 1 |
| Haga, N; Honjou, H; Ishibashi, K; Ishida, H; Ishiguro, T; Iwama, T; Kumamoto, K; Kuwabara, K; Ohsawa, T; Okada, N; Tajima, Y; Tsuji, Y | 1 |
| Amagasa, H; Ami, K; Ando, M; Arai, K; Fukuda, A; Ganno, H; Kurokawa, T; Nagahama, T; Nakamura, M; Okada, Y; Tei, S; Watayo, Y | 1 |
| Hakamada, K; Kawasaki, H; Kubo, N; Maruyama, A; Miyamoto, K; Takahashi, K; Wajima, N | 1 |
| Ajani, JA; Gong, Y; Gu, J; Hung, M; Izzo, JG; Pan, JY; Qin, A; Quin, A; Wu, X | 1 |
| Chehade, M; Selva, D; Simon, S; Temlett, J | 1 |
| Bang, YJ; Cha, Y; Han, SW; Im, SA; Keam, B; Kim, JW; Kim, M; Kim, MA; Kim, TY; Kim, WH; Lee, KH; Oh, DY | 1 |
| Asari, M; Honjoh, Y; Kasahara, A; Masuda, M; Miura, Y; Numata, K; Osaragi, T; Osawa, E; Rino, Y; Shibuya, H; Takizawa, K; Tsuchida, K; Yamamoto, Y; Yoneyama, K; Yoshida, T; Yoshie, K | 1 |
| Ishibashi, N; Kibe, S; Murakami, N; Ogata, Y; Shirouzu, K; Takahashi, K; Takeuchi, M; Uchida, S; Yahara, T | 1 |
| Endo, T; Hasegawa, H; Hoshino, G; Hoshino, H; Hoshino, Y; Ishii, Y; Kitagawa, Y; Matsunaga, A; Ochiai, H; Seo, Y; Shigeta, K | 1 |
| Adachi, K; Hirano, A; Imai, K; Koda, K; Kosugi, C; Nakagawa, R; Shiragami, R; Suzuki, M; Tezuka, T; Yamazaki, M; Yasuda, H | 1 |
| Adachi, K; Araki, O; Goto, N; Hashimoto, K; Hayashi, M; Itani, T; Matsumori, T; Mimura, J; Murakami, S; Sasaki, A; Shimada, Y; Tsuda, T | 1 |
| Akman, T; Atilla, K; Bora, S; Ellidokuz, H; Oztop, I; Sarioglu, S; Unek, IT; Unek, T; Yilmaz, U | 1 |
| Eguchi, S; Enjoji, A; Fujioka, H; Furui, J; Iwata, T; Kanematsu, T; Kanetaka, K; Kishikawa, H; Matsuo, S; Miyata, A; Nagata, Y; Shiogama, T | 1 |
| Inada, K; Inoue, S; Maeshiro, T; Miyamoto, S; Seyama, Y; Shida, D; Umekita, N | 1 |
| Chiba, T; Endo, F; Fujiwara, H; Ikeda, M; Ishida, K; Itabashi, T; Iwaya, T; Katagiri, H; Koeda, K; Kume, K; Maesawa, C; Matsuo, T; Nishizuka, SS; Noda, H; Otsuka, K; Sugai, T; Takahashi, M; Tamura, G; Uesugi, N; Wakabayashi, G; Yamada, N | 1 |
| Adams, R; Glynne-Jones, R; Gollins, S; Harrison, M; Jitlal, M; Meadows, HM; Sebag-Montefiore, D | 1 |
| Cho, WH; Choi, SK; Kim, SB; Kim, SM; Kwak, CH; Lee, B; Sir, JJ | 1 |
| Adachi, T; Goto, A; Itoh, M; Kanno, S; Kondo, Y; Mitsuhashi, K; Shinomura, Y; Suzuki, T; Wakasugi, H; Yabana, T | 1 |
| Dahl, O; Elsaleh, H; Fluge, Ø; Knudsen, ES; Leh, S; Li, Z; Myklebust, MP; Myrvold, HE; Pestell, RG; Rui, H; Tran, TH; Tveit, KM; Vonen, B | 1 |
| Ajani, JA; Benson, AB; Gunderson, LL; Haddock, MG; Mayer, RJ; Moughan, J; Pedersen, JE; Rich, TA; Thomas, CR; Willett, CG; Winter, KA | 1 |
| Hwang, DY; Jung, EJ; Kim, G; Ryu, CG | 1 |
| Abdullah, S; Khoshzaban, A; Mirakhorli, M; Rahman, SA; Rozafzon, R; Vakili, M | 1 |
| Endo, W; Fujie, Y; Fukunaga, H; Hojo, S; Maeura, Y; Ota, H; Shimizu, K; Toyoda, Y; Yoshioka, A; Yoshioka, S | 1 |
| Fukushima, M; Hoshino, M; Murakami, M; Naruse, H; Suzuki, N; Suzuki, S; Tominaga, K | 1 |
| Hou, MF; Lu, CY; Ma, CJ; Tsai, HL; Wang, JY; Wu, DC; Wu, IC; Yeh, YS | 1 |
| Hirata, K; Mizushima, Y; Okuya, K | 1 |
| Apple, D; Bougaran, R; Cochener, B; Colin, J; Pandey, S | 2 |
| Koda, K; Kodaira, S; Miyazaki, M; Nakazato, H; Ogawa, K; Saito, N; Sarashina, H; Suwa, T; Suzuki, M; Watanabe, S | 1 |
| Akarsu, C; Ergin, A; Taner, P | 1 |
| Cohen, MH; Griebel, DJ; Hirschfeld, S; Ibrahim, A; Pazdur, R; Williams, GA | 1 |
| Hirakawa, K; Hirata, K; Mitachi, Y; Nakata, B; Shirasaka, T; Tsuji, A; Yamamitsu, S | 1 |
| Fox, R; Melisko, ME; Venook, A | 1 |
| Aydemir, EH; Engin, B; Göksügür, N; Isçimen, A | 1 |
| Akiyama, S; Hibi, K; Ito, K; Kodera, Y; Nakao, A | 1 |
| Chonan, A; Fukuyama, Y; Hasegawa, K; Hayakawa, M; Ishikawa, K; Iwasaki, R; Koizumi, W; Kubo, Y; Kurihara, M; Maekawa, R; Miyoshi, K; Sasai, T; Yasutake, K | 1 |
| Elsner, P; Fuchs, S; Thiele, JJ; Ziemer, M | 1 |
| Buie, D; Chan, AK; Heine, J; Jenken, D; Johnson, D; Wong, A | 1 |
| Coward, J; Cunningham, D; Maisey, N | 1 |
| Bonadonna, G; Demicheli, R; Hrushesky, WJ; Miceli, R; Moliterni, A; Retsky, MW; Valagussa, P; Zambetti, M | 1 |
| Cree, IA; Di Nicolantonio, F; Di Palma, S; Fernando, A; Gabriel, FG; Glaysher, S; Gulliford, T; Higgins, B; Hurren, J; Johnson, P; Knight, LA; Lamont, A; Mercer, SJ; Sharma, S; Somers, SS; Toh, S; Whitehouse, PA; Yiangou, C | 1 |
| Amiraliev, NM | 1 |
| Brom, R; Candelaria, M; Cantu, D; Cetina, L; Chanona, J; de la Garza, J; Dolores, R; Duenas-Gonzalez, A; Gonzalez, A; Lopez-Graniel, C; Uribe, J | 1 |
| Coombes, RC; Ford, HT; Gazet, JC; Gray, R; Lowndes, S; McConkey, CC; Quilliam, J; Sutcliffe, R | 1 |
| Alvarez, E; Calvo, FA; Cortés, J; Del Valle, E; Díaz-González, JA; García-Sabrido, JL; Gómez-Espí, M; Muñoz-Jiménez, F | 1 |
| Davis, MD; Link, JS; Weick, JA | 1 |
| Bier, J; Gath, HJ; Oettle, H; Raguse, JD | 1 |
| Aktas, O; Dieste, FJ; Kreitsch, P; Paul, F; Vogel, HP; Zipp, F | 1 |
| Fayers, PM; Groenvold, M; Mouridsen, HT; Petersen, MA | 1 |
| Leelapatranura, K; Phonjan, T; Prabhasawat, P; Tesavibul, N | 1 |
| Honda, J; Miyoshi, T; Seike, J; Tangoku, A; Umemoto, A; Yoshida, T | 1 |
| Bardet, E; Beny, A; Bosset, JF; Calais, G; Collette, L; Daban, A; Maingon, P; Mineur, L; Ollier, JC; Radosevic-Jelic, L | 1 |
| Cossu Rocca, P; Costantino, S; Fadda, GM; Farris, A; Pinna, MA; Piredda, G; Putzu, C; Sanna, G; Santeufemia, DA; Sarobba, MG | 1 |
| Bedenne, L; Bonnetain, F; Bouché, O; Buecher, B; Chapet, O; Closon-Dejardin, MT; Conroy, T; Ducreux, M; Francois, E; Gérard, JP; Leduc, B; Mackiewicz, R; Maurel, J; Seitz, JF; Untereiner, M | 1 |
| Agrawal, RK; Bathers, S; Brunt, AM; Crawford, SM; Dunn, JA; Earl, HM; Fernando, IN; Foster, L; Grieve, RJ; Harvey, P; Hiller, L; Leonard, RC; Mansi, JL; McAdam, K; O'Reilly, SM; Poole, CJ; Rea, DW; Simmonds, P; Spooner, DA; Stanley, A; Twelves, CJ | 1 |
| Choi, SH; Heo, JS; Hong, YS; Hwang, IG; Kang, WK; Lee, J; Lee, SC; Lim, HY; Park, JO; Park, YS | 1 |
| Barone, C; Basso, M; Cassano, A; D'Argento, E; Di Leonardo, G; Landriscina, M; Pozzo, C; Quirino, M; Schinzari, G; Trigila, N | 1 |
| Adena, M; Damianovich, D; Tebbutt, NC | 1 |
| Costa, MN; Kara-José, N; Marcondes, AM; Sakano, E | 1 |
| Quinlan, M; Savant, V; Tomlins, PJ | 1 |
| Allegrini, G; Andreuccetti, M; Barbara, C; Benedetti, G; Brunetti, I; Chiara, S; Cortesi, E; Crinò, L; Evangelista, W; Falcone, A; Fanchini, L; Fioretto, L; Granetto, C; Masi, G; Orlandini, C; Pfanner, E; Picone, V; Porcile, G; Ricci, S; Vitello, S | 1 |
| Caron, P; Liu, D; Patel, S; Seiter, K | 1 |
| Brackstone, M; Chambers, AF; Townson, JL | 1 |
| Alonso, C; Altés, A; Baiget, M; Barnadas, A; Del Rio, E; Paré, L; Ramón y Cajal, T; Sedano, L | 1 |
| Ahn, BM; Baek, JH; Chae, YS; Cho, YY; Choi, GS; Jun, SH; Kim, JG; Kim, SN; Lee, IT; Lee, SJ; Moon, JH; Sohn, SK | 1 |
| Delladetsima, J; Gouveris, P; Kyriakou, V; Lazaris, AC; Nonni, A; Papathomas, TG; Patsouris, ES; Tsavaris, N | 1 |
| Meropol, NJ | 1 |
| Azuara, D; Biondo, S; Capella, G; de Oca, J; Hotter, G; Martí-Ragué, J; Moreno, V; Navarro, M; Osorio, A; Rafecas, A; Sanchez-Santos, R; Sola, A | 1 |
| Alberts, SR; Fitch, TR; Foster, NR; Jatoi, A; Lair, BS; Martenson, JA; McLeod, HL; Moore, DF; Nichols, F; Tschetter, LK | 1 |
| Jia, YJ; Li, CG; Li, ML; Li, MX; Qin, ZH; Shu, XH | 1 |
| Fujii, H; Inoue, A; Inoue, M; Inoue, S; Kunitomo, K; Takahashi, H | 1 |
| Dietze, O; Filipits, M; Gnant, MF; Greil, R; Grill, R; Huynh, A; Jakesz, R; Kwasny, W; Lax, S; Lehnert, M; Rudas, M; Schippinger, W; Singer, C; Stierer, M; Stiglbauer, W | 1 |
| Hachisuka, Y; Hatano, H; Johira, H; Kamei, Y; Kawata, N; Kimura, M; Miyata, N; Ohmori, K; Umeoka, T; Uomoto, M; Watanabe, R; Yunoki, S | 1 |
| Bae, SB; Cho, DY; Cho, IS; Han, CS; Kim, S; Lee, HJ; Lee, KT; Park, JC; Park, SY; Yun, HJ | 1 |
| Albaugh, JS; Keeffe, EB; Krippaehne, WW | 1 |
| Jacobs, C; Mead, GM | 1 |
| Iijima, S; Kawagoe, K; Sasaki, J | 1 |
| Amadeo, JH; Higgins, GA; Keehn, RJ; McCaughan, JJ; McElhinney, J | 1 |
| Wilson, RE | 1 |
| Cadman, EC; Cross, J; Glick, JH; Horton, J; Taylor, SG | 1 |
| Kaufmann, R; Landes, E | 1 |
| Adams, JW; Bofenkamp, TM; Kobrin, J; Wirtschafter, JD; Zeese, JA | 1 |
| Barker, JL; Montague, ED; Peters, LJ | 1 |
| Endo, H; Himeno, K; Hirohata, T; Nomoto, K; Tomita, Y | 1 |
| Cassell, PC; Ellis, H; Evans, MG; Gilbert, JM; Hellmann, K; Stoodley, BJ; Wastell, C | 1 |
| Bates, TS; Brinkley, D; Edelstyn, GA; Evans, RG; Kitchen, G; MacRae, KD; Nicol, NT; Spittle, M; Wheeler, TK | 1 |
| Debanne, SM; Eckert, C; Flynn, WJ; Hermann, RE; Hubay, CA; Jones, JC; Mansour, EG; Marshall, JS; McGuire, WL; Pearson, OH; Rhodes, RS | 1 |
| Cunningham, T; Dao, TL; Horton, J; Nemoto, T; Rosner, D; Simon, R; Snyderman, M; Sponzo, R | 1 |
| Eubanks, SW; Gentry, RH; May, DL; Patterson, JW | 1 |
| Bruckner, H; Cohen, CJ; Deppe, G; Jacobs, AJ | 1 |
| Clark, GM; Knight, WA; McGuire, WL; Osborne, CK | 1 |
| Cano-Parra, J; Cisneros, AL; Maldonado, MJ; Menezo, JL; Navea-Tejerina, A; Vila, E | 1 |
| Eiermann, W; Harbeck, N; Pache, L; Untch, M | 1 |
| Demetri, GD; Kaplan, WD; Salgia, R | 1 |
| Bacoyiannis, C; Daliani, D; Katsikas, M; Kosmas, C; Kosmidis, P; Sakelaropoulos, N; Tentas, K; Tsavaris, N | 1 |
| Guoth, JG; Husseinzadeh, N; Jayawardena, DS | 1 |
| Barraclough, B; Boyages, J; Langlands, AO; Ung, O | 1 |
| Lin, DY | 1 |
| Dzubow, LM | 1 |
| Burch, PA; Cha, SS; Gunderson, LL; Mailliard, JA; Martenson, JA; McKenna, PJ; Moertel, CG | 1 |
| Bari, M; Bruscagnin, G; Gatti, C; Gion, M; Leon, AE; Mione, R; Nascimben, O; Pappagallo, GL; Vinante, O | 1 |
| Creaven, P; Herrera, L; Petrelli, NJ; Rodriguez-Bigas, M; Rustum, Y | 1 |
| Byers, RM; Dimery, IW; Goepfert, H; Guillory, C; Hong, WK; McCarthy, K; Morrison, WH; Peters, LJ; Weber, RS | 1 |
| Cummings, BJ; Danjoux, C; Hodson, I; Keane, TJ; MacKenzie, R; O'Sullivan, B; Payne, D; Rawlinson, E | 1 |
| Andreoli, F; Borrelli, D; Bruno, L; Cini, G; de Leonardis, V; Fabbroni, S; Intini, C; Neri, B; Pernice, LM; Romano, S; Valeri, A | 1 |
| Amadori, S; Bendandi, M; Falini, B; Gherlinzoni, F; Mandelli, F; Martelli, M; Martelli, MF; Pileri, SA; Sabattini, E; Tura, S; Zinzani, PL | 1 |
| Ando, N; Ide, H; Iizuka, T; Ishida, K | 1 |
| Kramer, N; Leitner, SP; Michaelson, RA; Rosenstein, ED | 1 |
| Buckner, JC; Cascino, TL; Goldberg, RM; Kuross, SA; Levitt, R; Morton, RF; O'Fallon, JR; Scheithauer, BW; Veeder, MH; Wiesenfeld, M | 1 |
| Sugarbaker, PH; Zoetmulder, FA | 1 |
| Haller, DG; Kahn, MJ; Macdonald, JS; Mailliard, JA; Mayer, RJ; O'Connell, MJ; Wieand, HS | 1 |
| Gordon, S; Korey, A; Kraus, S; McCarty, JM; Orenberg, EK; Phillips, S; Skinner, R; Sperling, M; Swinehart, JM; Webster, GF | 1 |
| Burakowski, J; Fijałkowska, A; Filipecki, S; Szturmowicz, M; Tomkowski, W | 1 |
| Falkson, G; Gilchrist, KW; Neuberg, D; Olson, JE; Pandya, KJ; Richter, MP; Solin, LJ; Tormey, DC; Veeder, M | 1 |
| Ariyoshi, A; Iguchi, A; Kumazawa, J; Kuriya, N; Naito, S; Omoto, T; Osada, Y; Sagiyama, K | 1 |
| Korey, A; Orenberg, EK; Swinehart, JM | 1 |
| Horiguchi, J; Iino, Y; Koibuchi, Y; Maemura, M; Morishita, Y; Nagaoka, H; Oyama, T; Takei, H; Yokoe, T | 1 |
| Bitran, JD; Grad, G; Grinblatt, DL; Laport, GF; Williams, SF | 1 |
| Hara, R; Isobe, K; Ito, H; Kawada, T; Kitahara, H; Kubo, A; Machida, N; Shigematsu, N; Takano, H; Uchida, Y; Uno, T; Yasuda, S | 1 |
| Korey, A; McCarty, JM; Miller, BH; Orenberg, EK; Skinner, RB; Swinehart, JM; Tyring, SK | 1 |
| Brodowicz, T; Depisch, D; Fiebiger, WC; Hejna, M; Kornek, GV; Raderer, M; Scheithauer, W | 1 |
| Chang, KJ; Chang, YS; Chen, YC; Cheng, AL; Lin, DT; Lin, JF; Lin, MT; Lui, LT; Tang, JL; Yeh, KH; Yu, SC | 1 |
| Duchesne, B; Gautier, S; Jallet, V; Parel, JM; Tahi, H; Villain, F | 1 |
| Bonadonna, G; Brambilla, C; Demicheli, R; Ferrari, L; Miceli, R; Moliterni, A; Valagussa, P; Zambetti, M | 1 |
| Inoue, H; Kim, R; Murakami, S; Ohi, Y; Toge, T; Yoshida, K | 1 |
| Fridrik, M; Gnant, M; Haider, K; Hausmaninger, H; Jakesz, R; Kolb, R; Kubista, E; Manfreda, D; Mittlböck, M; Mlineritsch, B; Samonigg, H; Steger, G; Steindorfer, P; Stierer, M; Tschurtschenthaler, G | 1 |
| Leung, HY; Powell, PH; West, AF | 1 |
| Androulakis, N; Aravantinos, G; Bafaloukos, D; Florou, S; Fountzilas, G; Georgoulias, V; Kosmidis, P; Sgouros, I; Skarlos, DV | 1 |
| Boukis, H; Janinis, J; Lefantzis, D; Panagos, G; Papadakou, M; Poulis, A; Xidakis, E | 1 |
| Grobbelaar, AO; Jemec, B; Linge, C; McGrouther, DA; Sanders, R; Smith, PJ | 1 |
| Ansaloni, L; Bazzocchi, R; Bini, A; Grazia, M; Stella, F; Zompatori, M | 1 |
| Chang, JT; Chen, WC; Hong, JH; See, LC; Tang, SG; Tsang, S | 1 |
| Chi, KH; Hsieh, MC; Lo, SS; Lui, WY; Shen, KH; Tseng, HS; Wu, CW | 1 |
| Mamounas, EP | 1 |
| Calvano, C; Simon, JW; Stern, JH | 1 |
| Kawahara, M; Nashimoto, A; Yabusaki, H | 1 |
| Amato, R | 1 |
| Ophir, A; Pikkel, J; Porges, Y | 1 |
| Hahn, EG; Hanke, B; Happich, K; Himmler, B; Hohenberger, W; Lampert, S; Martus, P; Parsch, H; Riedel, C; Wein, A | 1 |
| Ahn, JB; Chung, HC; Jeung, HC; Kim, BS; Kim, NK; Min, JS; Rha, SY; Roh, JK; Shim, KY; Yoo, NC | 1 |
| Delozier, T; Duchateau, L; Floiras, JL; Julien, JP; van de Velde, CJ; van der Hage, JA; Vandervelden, C | 1 |
| Duan, Y; Guan, Z; Liu, X; Song, S; Wu, S; Yang, L; Yu, J | 1 |
| Malik, AA; Mehdi, SA; Moazzam, N; Potti, A | 1 |
| Bertino, JR; Boston, B; Capizzi, RL | 1 |
| Stoll, BA | 1 |
| Andersson, L; Edsmyr, F | 1 |
| Blumenschein, GR; Buzdar, AU; Gutterman, JU; Hersh, EM; Hortobagyi, GN; Krutchik, AN; Tashima, CK; Yap, HY | 1 |
| Boldrey, EB; Hoffman, WF; Levin, VA; Pischer, TL; Seager, ML; Wilson, CB | 1 |
| deKernion, JB | 1 |
| Bross, ID; Prout, GR; Slack, NH | 1 |
| Fisher, B | 1 |
| Bonadonna, G; Rossi, A; Valagussa, P | 1 |
| Amgwerd, R; Bigler, R; Enderlin, F; Engelhart, G; Heinz, C; Hochuli, E; Jungi, WF; Lanz, R; Senn, HJ; Simeon, B; Sprenger, F; Wick, A | 1 |
| Dalgat, DM | 1 |
| Mayr, AC; Senn, HJ | 1 |
| Breitbart, EW | 1 |
| Carter, SK | 1 |
| Frei, E; Lokich, JJ; Mayer, RJ; Skarin, AT | 1 |
| Blumenschein, GR; Buzdar, AU; Freireich, EJ; Gehan, EA; Gutterman, JU; Hersh, EM; Hortobagyi, GN; Smith, TL; Tashima, CK | 1 |
| Tormey, DC; Waalkes, TP | 1 |
| Cheng, FC; Lee, CM; Ong, GB | 1 |
| Ferguson, DJ; Harper, PV | 1 |
| Brown, PW; Donaldson, M; Horsley, S; Lawrence, W; Lovett, WL; Regelson, W; Ruffner, BW; Terz, JJ | 1 |
| Goncalves, JC | 2 |
| Bajetta, E; Bonadonna, G; Brambilla, C; Brugnatelli, L; Brusamolino, E; De Lena, M; Musumeci, R; Rossi, A; Tancini, G; Valagussa, P; Veronesi, U | 1 |
| Berbaum, K; Cragg, AH; Smith, TP; Stoll, LL | 1 |
| Kinney, WK; Mesic, JB; Rosenberg, PJ; Russell, AH; Scudder, SA; Smith, LH; Taylor, MH; Townsend, DE; Trelford, JD; Zukowski, CL | 1 |
| Blessing, JA; DeGeest, K; Look, KY; Muss, HB | 1 |
| Blessing, JA; Look, KY; Malfetano, JH; Muss, HB; Partridge, EE | 1 |
| Labianca, R; Luporini, G | 1 |
| Carpenter, JT; Levine, EG; Raczynski, JM | 1 |
| Falliers, CJ | 1 |
| Bergman, A; Nalick, R | 1 |
| Braumann, D; Günzl, C; Lewerenz, B; Mainzer, K | 1 |
| Carpiniello, VL; Malloy, TR; Schoenberg, M | 1 |
| Falkson, G; Falkson, HC; Gillchrist, KW; Gray, R; Harris, JE; Tormey, DC; Wolberg, WH | 1 |
| Seitz, JF | 1 |
| Bell, B; Brecher, ML; Cushing, B; Green, DM; Krischer, JP; Whitehead, VM | 1 |
| Dinçol, D; Içli, F; Isikman, E; Unal, M | 1 |
| Bartoli, C; Bonadonna, G; Brambilla, C; Coopmans de Yoldi, G; Ferrari, L; Greco, M; Luini, A; Rilke, F; Veronesi, U; Zucali, R | 1 |
| Krusinski, PA; Nunnink, JC; Yates, JW | 1 |
| Wei, XY; Zhou, XM | 1 |
| Larson, PO | 1 |
| Takenaka, A | 1 |
| Rosemberg, SK | 2 |
| al-Sarraf, M; Ensley, JF; Kish, JA; Kloner, R; Patel, B; Wynne, J | 1 |
| Bassot, V; Brasnu, D; Chodkiewicz, JL; Donadieu, S; Laccourreye, H; Menard, M; Nguyen, S; Roux, FX | 1 |
| Krebs, HB | 1 |
| Camaggi, CM; Cilenti, G; Fruet, F; Martoni, A; Pannuti, F | 1 |
| Cascinelli, N; Greco, M; Leo, E | 1 |
| Lee, YT | 1 |
| Arizuka, S; Ashida, Y; Kinami, Y; Miyazaki, I; Takashima, S; Tanaka, T | 1 |
| Amadori, S; Anselmo, AP; Biagini, C; Cimino, G; Guglielmi, C; Mandelli, F; Papa, G; Ruco, LP | 1 |
| Byland, W; Nagel, G; Senn, HJ | 1 |
| Decker, DG; Jorgensen, EO; Malkasian, GD; Webb, MJ | 1 |
| Vitvitskiĭ, KF | 1 |
| Sugai, T; Tsuji, T | 1 |
| Hunziker, N; Laugier, P | 1 |
22 review(s) available for fluorouracil and Recrudescence
| Article | Year |
|---|---|
5-Fluorouracil in primary, impending recurrent and recurrent pterygium: Systematic review of the efficacy and safety of a surgical adjuvant and intralesional antimetabolite.
Topics: Antimetabolites; Conjunctiva; Fluorouracil; Follow-Up Studies; Humans; Immunosuppressive Agents; Injections, Intralesional; Pterygium; Recurrence; Treatment Outcome | 2022 |
A review of actinic keratosis, skin field cancerisation and the efficacy of topical therapies.
Topics: Antineoplastic Agents; Diclofenac; Disease Progression; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Recurrence; Skin Neoplasms | 2021 |
Keloids: a review of therapeutic management.
Topics: Fluorouracil; Humans; Injections, Intralesional; Keloid; Recurrence; Steroids | 2021 |
Comparison among adjuvant treatments for primary pterygium: a network meta-analysis.
Topics: Adjuvants, Immunologic; Alkylating Agents; Chemotherapy, Adjuvant; Conjunctiva; Cyclosporine; Fluorouracil; Humans; Immunosuppressive Agents; Mitomycin; Network Meta-Analysis; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Pterygium; Randomized Controlled Trials as Topic; Recurrence; Transplantation, Autologous | 2018 |
[A Case of Hyperammonemia Induced by Chemotherapy with 5-Fluorouracil for Metastatic Colon Cancer].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Colonic Neoplasms; Fluorouracil; Humans; Hyperammonemia; Male; Recurrence; Treatment Outcome | 2018 |
5-Flouorouracil Is an Attractive Medical Treatment in Women With Vaginal Intraepithelial Neoplasia: A Meta-Analysis.
Topics: Antineoplastic Agents; Carcinoma in Situ; Female; Fluorouracil; Humans; Observational Studies as Topic; Recurrence; Treatment Outcome; Vaginal Neoplasms | 2018 |
[A case of recurrent colon cancer involved in multiple organs maintaining complete response over the long-term after chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Neoplasm Metastasis; Organoplatinum Compounds; Recurrence; Time Factors | 2013 |
[A case of long-term survival after low-dose FP systemic chemotherapy for a tumor thrombus in the inferior caval vein and multiple lung metastases from recurrent hepatocellular carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Male; Recurrence; Thrombosis; Time Factors; Vena Cava, Inferior | 2014 |
[A CASE OF SOLITARY ADRENAL TUMOR METASTASIZED FROM RECTAL CANCER].
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Adrenalectomy; Aged; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Fluorouracil; Humans; Leucovorin; Male; Organoplatinum Compounds; Rectal Neoplasms; Recurrence; Tomography, X-Ray Computed | 2015 |
[Resection of the Right External Iliac Artery and Vein after Local Recurrence of Cecal Cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cecal Neoplasms; Chemotherapy, Adjuvant; Deoxycytidine; Female; Fluorouracil; Humans; Iliac Artery; Iliac Vein; Middle Aged; Oxaloacetates; Recurrence | 2015 |
Topical treatment of field cancerization.
Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Diclofenac; Fluorouracil; Humans; Imiquimod; Immunosuppression Therapy; Immunosuppressive Agents; Keratosis, Actinic; Organ Transplantation; Photochemotherapy; Recurrence; Skin Neoplasms; Tissue Distribution | 2009 |
Management of keloids and hypertrophic scars.
Topics: Bleomycin; Cicatrix, Hypertrophic; Cryotherapy; Fluorouracil; Glucocorticoids; Humans; Keloid; Recurrence; Risk Factors; Time Factors; Tocopherols; Treatment Outcome; Verapamil; Wound Healing | 2009 |
[Operative techniques for surgical treatment of primary and recurrent pterygia].
Topics: Antimetabolites, Antineoplastic; Astigmatism; Biological Dressings; Combined Modality Therapy; Conjunctiva; Fibrin Tissue Adhesive; Fluorouracil; Humans; Postoperative Complications; Pterygium; Recurrence; Reoperation; Stem Cell Transplantation; Sutures; Visual Acuity | 2010 |
[Recurrent autoimmune hemolytic anemia induced by XELOX chemotherapy for colon cancer].
Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Recurrence | 2011 |
[FOLFIRI with bevacizumab chemotherapy for a patient with recurrence of rectal cancer under haemodialysis for chronic renal failure].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Female; Fluorouracil; Humans; Kidney Failure, Chronic; Leucovorin; Liver Neoplasms; Lung Neoplasms; Middle Aged; Rectal Neoplasms; Recurrence | 2012 |
[A case report of primary small cell esophageal carcinoma responding successfully to radiochemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemoradiotherapy; Cisplatin; Esophageal Neoplasms; Fatal Outcome; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Recurrence | 2012 |
Changing role of chemotherapy in treatment of head and neck cancer.
Topics: Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Therapy, Combination; Fluorouracil; Head and Neck Neoplasms; Humans; Hydroxyurea; Methotrexate; Recurrence | 1982 |
Bilateral recurrent pneumothorax complicating chemotherapy for pulmonary metastatic breast ductal carcinoma: report of a case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Drainage; Female; Fluorouracil; Follow-Up Studies; Humans; Lung Neoplasms; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Pneumothorax; Recurrence; Treatment Outcome | 2000 |
The chemotherapy of advanced bladder carcinoma.
Topics: Antineoplastic Agents; Cyclophosphamide; Doxorubicin; Fluorouracil; Humans; Injections, Intra-Arterial; Methotrexate; Mitomycins; Neoplasm Metastasis; Recurrence; Research Design; Urinary Bladder Neoplasms | 1977 |
Biochemical markers in cancer of the breast.
Topics: Breast Neoplasms; Cadaverine; Carcinoembryonic Antigen; Chorionic Gonadotropin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Guanosine; Humans; Inosine; Methotrexate; Neoplasm Metastasis; Prognosis; Putrescine; Recurrence; Spermidine; Spermine | 1976 |
[Adjuvant chemotherapy in colonic cancer].
Topics: Colonic Neoplasms; Drug Therapy, Combination; Fluorouracil; Humans; Leucovorin; Levamisole; Postoperative Care; Recurrence; Semustine | 1990 |
Patterns of metastasis and natural courses of breast carcinoma.
Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Receptors, Estrogen; Recurrence | 1985 |
99 trial(s) available for fluorouracil and Recrudescence
| Article | Year |
|---|---|
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402.
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Fluorouracil; Humans; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Rectal Neoplasms; Recurrence | 2023 |
Efficacy and safety of XELOX combined with anlotinib and penpulimab vs XELOX as an adjuvant therapy for ctDNA-positive gastric and gastroesophageal junction adenocarcinoma: a protocol for a randomized, controlled, multicenter phase II clinical trial (EXPL
Topics: Adenocarcinoma; Clinical Trials, Phase II as Topic; Esophagogastric Junction; Fluorouracil; Humans; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Oxaliplatin; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence | 2023 |
The efficacy of microneedling alone vs its combination with 5-fluorouracil solution vs 5-fluorouracil intralesional injection in the treatment of plantar warts.
Topics: Fluorouracil; Humans; Injections, Intralesional; Pain; Recurrence; Treatment Outcome; Warts | 2020 |
Strontium-90 brachytherapy following intralesional triamcinolone and 5-fluorouracil injections for keloid treatment: A randomized controlled trial.
Topics: Adult; Brachytherapy; Elastic Modulus; Elasticity Imaging Techniques; Female; Fluorouracil; Humans; Injections, Intralesional; Keloid; Male; Recurrence; Strontium Radioisotopes; Triamcinolone Acetonide; Young Adult | 2021 |
Comparison of efficacy and safety of intralesional triamcinolone and combination of triamcinolone with 5-fluorouracil in the treatment of keloids and hypertrophic scars: Randomised control trial.
Topics: Adult; Body Piercing; Burns; Cicatrix, Hypertrophic; Double-Blind Method; Drug Therapy, Combination; Female; Fluorouracil; Glucocorticoids; Humans; Immunosuppressive Agents; Injections, Intralesional; Keloid; Male; Recurrence; Treatment Outcome; Triamcinolone; Wounds and Injuries; Young Adult | 2019 |
Topical cyclosporine A 0.05% before and after surgery to prevent pterygium recurrence.
Topics: Adult; Combined Modality Therapy; Conjunctiva; Corneal Diseases; Cyclosporine; Female; Fluorouracil; Humans; Immunosuppressive Agents; Male; Middle Aged; Ophthalmic Solutions; Postoperative Care; Preoperative Care; Prospective Studies; Pterygium; Recurrence; Surgical Flaps; Young Adult | 2019 |
Adjuvant 5-flurouracil, alpha-interferon and interleukin-2 versus observation in patients at high risk of recurrence after nephrectomy for renal cell carcinoma: results of a phase III randomised European Organisation for Research and Treatment of Cancer (
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Disease Progression; Female; Fluorouracil; Humans; Incidence; Interferon-alpha; Interleukin-2; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Nephrectomy; Quality of Life; Recurrence; Risk Factors; Surveys and Questionnaires | 2014 |
Comparison of short-term efficacy and safety of TIROX and DCF regimens for advanced gastric cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Irinotecan; Leukopenia; Lymphatic Metastasis; Male; Middle Aged; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Prospective Studies; Recurrence; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome | 2014 |
A comparison of a 5% potassium hydroxide solution with a 5-fluorouracil and salicylic acid combination in the treatment of patients with anogenital warts: a randomized, open-label clinical trial.
Topics: Administration, Topical; Adult; Anti-Infective Agents; Condylomata Acuminata; Dermatologic Agents; Drug Combinations; Female; Fluorouracil; Humans; Hydroxides; Immunosuppressive Agents; Male; Potassium Compounds; Recurrence; Salicylic Acid | 2014 |
A phase II study of S-1 chemotherapy with concurrent thoracic radiotherapy in elderly patients with locally advanced non-small-cell lung cancer: the Okayama Lung Cancer Study Group Trial 0801.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Survival; Drug Combinations; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Oxonic Acid; Recurrence; Tegafur; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
A prospective randomized exploratory study comparing the efficacy of once-daily topical 0.5% 5-fluorouracil in combination with 10.0% salicylic acid (5-FU/SA) vs. cryosurgery for the treatment of hyperkeratotic actinic keratosis.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Cryosurgery; Drug Combinations; Facial Dermatoses; Female; Fluorouracil; Humans; Immunosuppressive Agents; Keratolytic Agents; Keratosis, Actinic; Male; Middle Aged; Prospective Studies; Recurrence; Salicylic Acid; Scalp; Severity of Illness Index; Treatment Outcome | 2015 |
5-Fluorouracil vs avastin as adjunct to conjunctival autograft in the surgical treatment of pterygium.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antimetabolites; Autografts; Bevacizumab; Combined Modality Therapy; Conjunctiva; Female; Fluorouracil; Humans; Intravitreal Injections; Male; Middle Aged; Prospective Studies; Pterygium; Recurrence; Vascular Endothelial Growth Factor A | 2016 |
Randomized phase II trial of TEGAFIRI (tegafur/uracil, oral leucovorin, irinotecan) compared with FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) in patients with unresectable/recurrent colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Disease Progression; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Odds Ratio; Proportional Hazards Models; Recurrence; Tegafur; Treatment Failure; Treatment Outcome | 2016 |
A pilot study of oxaliplatin, fluorouracil and folinic acid (FOLFOX-6) as first-line chemotherapy in advanced or recurrent gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Pilot Projects; Recurrence; Stomach Neoplasms; Survival Rate | 2008 |
Phase II trial of neoadjuvant cisplatin, 5-fluorouracil and interferon-alpha in operable squamous cell carcinoma of the esophagus.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dose-Response Relationship, Drug; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Interferon-alpha; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Recurrence; Survival Rate | 2008 |
Q-TWiST analysis of lapatinib combined with capecitabine for the treatment of metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Disease Progression; Female; Fluorouracil; Humans; Lapatinib; Neoplasm Metastasis; Quinazolines; Recurrence; Survival Analysis | 2008 |
Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease Progression; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Hydroxyurea; Male; Neoplasm Metastasis; Postoperative Period; Recurrence; Salvage Therapy; Treatment Outcome | 2008 |
A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Disease-Free Survival; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Recurrence; Risk Assessment | 2009 |
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cetuximab; Deoxycytidine; Disease-Free Survival; ErbB Receptors; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Oxaloacetates; Prospective Studies; Recurrence; Stomach Neoplasms; Treatment Outcome | 2011 |
Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research Consortium.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Organoplatinum Compounds; Oxaliplatin; Recurrence; Retreatment; Salvage Therapy | 2010 |
A phase II study of combination chemotherapy with capecitabine and cisplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Metastasis; Recurrence | 2011 |
Long-term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Recurrence; Risk Assessment; Risk Factors; Survival Analysis; Time Factors; Treatment Outcome | 2011 |
A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Chemotherapy, Adjuvant; Colorectal Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Quality of Life; Recurrence; Treatment Outcome | 2010 |
Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; DNA Mismatch Repair; DNA Mutational Analysis; England; Fluorouracil; Humans; Immunohistochemistry; Leucovorin; Mutation; MutL Protein Homolog 1; MutS Homolog 2 Protein; Neoplasm Staging; Nuclear Proteins; Odds Ratio; Patient Selection; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); ras Proteins; Recurrence; Risk Assessment; Risk Factors; Time Factors; Tissue Array Analysis; Treatment Outcome | 2011 |
Multicenter phase I/II study of docetaxel, cisplatin and fluorouracil combination chemotherapy in patients with advanced or recurrent squamous cell carcinoma of the esophagus.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Esophageal Neoplasms; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Recurrence; Taxoids; Treatment Outcome | 2011 |
[Chemotherapy in patients with non-resectable colorectal cancer metastases to the liver: systemic or regional?].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Irinotecan; Kaplan-Meier Estimate; Leucovorin; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Recurrence; Splenic Neoplasms; Treatment Outcome | 2011 |
Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Paclitaxel; Recurrence; Treatment Outcome | 2012 |
Effects of intermittent 5-fluorouracil and low-dose cisplatin therapy on advanced and recurrent gastric cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Humans; Male; Middle Aged; Recurrence; Stomach Neoplasms | 2012 |
Prognostic factors for recurrence and survival in anal cancer: generating hypotheses from the mature outcomes of the first United Kingdom Coordinating Committee on Cancer Research Anal Cancer Trial (ACT I).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Chemoradiotherapy; Female; Fluorouracil; Hemoglobins; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Prognosis; Prospective Studies; Recurrence; Survival Rate; Treatment Outcome; United Kingdom | 2013 |
Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Colorectal Neoplasms; Combined Modality Therapy; Cyclin D1; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Immunohistochemistry; Levamisole; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Recurrence; Treatment Outcome | 2012 |
Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Chemoradiotherapy; Cisplatin; Colostomy; Disease-Free Survival; Female; Fluorouracil; Humans; Male; Mitomycin; Neoplasm Metastasis; Recurrence; Survival Analysis; Survival Rate; Young Adult | 2012 |
A randomized controlled trial of postoperative adjuvant immunochemotherapy for colorectal cancer with oral medicines.
Topics: Adjuvants, Immunologic; Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Female; Floxuridine; Fluorouracil; Humans; Immunosuppressive Agents; Lymphatic Metastasis; Male; Middle Aged; Prognosis; Recurrence; Time Factors; Treatment Outcome | 2003 |
FDA drug approval summaries: oxaliplatin.
Topics: Antineoplastic Agents; Camptothecin; Colorectal Neoplasms; Disease Progression; Drug Approval; Drug Therapy, Combination; Fluorouracil; Humans; Infusions, Intravenous; Irinotecan; Leucovorin; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Random Allocation; Recurrence; United States; United States Food and Drug Administration | 2004 |
Combination phase I trial of a novel oral fluorouracil derivative S-1 with low-dose cisplatin for unresectable and recurrent gastric cancer (JFMC27-9902).
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Leukopenia; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Patient Selection; Recurrence; Stomach Neoplasms | 2004 |
Intralesional 5-fluorouracil, lidocaine and epinephrine mixture for the treatment of verrucae: a prospective placebo-controlled, single-blind randomized study.
Topics: Adolescent; Adult; Anesthetics, Local; Antimetabolites; Drug Combinations; Epinephrine; Fluorouracil; Humans; Injections, Intralesional; Lidocaine; Middle Aged; Recurrence; Single-Blind Method; Vasoconstrictor Agents; Warts | 2004 |
Prolonged cytostatic tumor dormancy induced by serial exchange of chemotherapy in colorectal carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Cisplatin; Clinical Trials as Topic; Colorectal Neoplasms; Fluorouracil; Humans; Immunoenzyme Techniques; Male; Neoplasm Metastasis; Recurrence; Time Factors; Treatment Outcome | 2004 |
Sequence-dependence of cisplatin and 5-fluorouracil in advanced and recurrent gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Female; Fluorouracil; Humans; Male; Middle Aged; Recurrence; Stomach Neoplasms; Time Factors; Treatment Outcome | 2004 |
Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Female; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Odds Ratio; Prognosis; Radiotherapy Dosage; Rectal Neoplasms; Recurrence; Survival Rate | 2005 |
Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Fluorouracil; Humans; Mastectomy; Methotrexate; Neoplasm Metastasis; Recurrence | 2005 |
[Neoajuvant polychemotherapy at the complex treatment of the patients with laryngeal cancer].
Topics: Antineoplastic Agents; Cisplatin; Female; Fluorouracil; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Recurrence; Treatment Outcome | 2002 |
Long-term follow-up of a randomised trial designed to determine the need for irradiation following conservative surgery for the treatment of invasive breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Mastectomy, Segmental; Methotrexate; Middle Aged; Receptors, Estrogen; Recurrence | 2006 |
Oxaliplatin, folinic acid and 5-fluorouracil (OFF) in patients with recurrent advanced head and neck cancer: a phase II feasibility study.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Therapy, Combination; Feasibility Studies; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Leucovorin; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Quality of Life; Recurrence; Treatment Outcome; Vitamin B Complex | 2006 |
Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Ovary; Quality of Life; Recurrence; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2006 |
Efficacy of subconjunctival 5-fluorouracil and triamcinolone injection in impending recurrent pterygium.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Conjunctiva; Disease Progression; Female; Fluorouracil; Follow-Up Studies; Glucocorticoids; Humans; Injections; Injections, Intralesional; Male; Middle Aged; Prospective Studies; Pterygium; Recurrence; Survival Analysis; Treatment Outcome; Triamcinolone Acetonide | 2006 |
Chemotherapy with preoperative radiotherapy in rectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Postoperative Care; Postoperative Complications; Preoperative Care; Rectal Neoplasms; Recurrence; Survival Analysis | 2006 |
Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Radiotherapy; Rectal Neoplasms; Recurrence; Vitamin B Complex | 2006 |
Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Quality of Life; Recurrence; Survival Analysis | 2006 |
Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Cisplatin; Deoxycytidine; Disease Progression; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Recurrence; Survival Analysis | 2007 |
Schedule-dependent activity of 5-fluorouracil and irinotecan combination in the treatment of human colorectal cancer: in vitro evidence and a phase I dose-escalating clinical trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Cell Cycle; Cell Proliferation; Chemotherapy, Adjuvant; Cohort Studies; Colorectal Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Feasibility Studies; Female; Fluorouracil; HT29 Cells; Humans; Infusions, Intravenous; Irinotecan; Male; Maximum Tolerated Dose; Middle Aged; Recurrence; Treatment Outcome | 2007 |
Endoscopic study of the intranasal ostium in external dacryocystorhinostomy postoperative. Influence of saline solution and 5-fluorouracil.
Topics: Antimetabolites; Dacryocystitis; Dacryocystorhinostomy; Endoscopy; Fluorouracil; Follow-Up Studies; Humans; Nasal Mucosa; Postoperative Period; Recurrence; Sodium Chloride; Statistics, Nonparametric; Treatment Outcome | 2007 |
Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nor
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Quality of Life; Recurrence; Survival Analysis | 2007 |
Paclitaxel, carboplatin, 5-fluorouracil, and radiation for locally advanced esophageal cancer: phase II results of preliminary pharmacologic and molecular efforts to mitigate toxicity and predict outcomes: North Central Cancer Treatment Group (N0044).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Neoplasm Staging; Paclitaxel; Patient Selection; Radiotherapy; Recurrence; Survival Analysis; Survivors; Time Factors | 2007 |
Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy.
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclin D1; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Goserelin; Humans; Methotrexate; Middle Aged; Prognosis; Receptors, Cytoplasmic and Nuclear; Recurrence; Tamoxifen; Treatment Outcome | 2008 |
Phase II trial of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin in patients with advanced or recurrent inoperable gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Paclitaxel; Recurrence; Stomach Neoplasms; Survival Analysis | 2009 |
Efficacy of prolonged intermittent therapy with combined 5-fluorouracil and methyl-CCNU following resection for carcinoma of the large bowel. A Veterans Administration Surgical Oncology Group report.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Gastrointestinal Diseases; Hematologic Diseases; Humans; Middle Aged; Random Allocation; Rectal Neoplasms; Recurrence; Semustine | 1984 |
Adjuvant therapy for colo-rectal cancer.
Topics: Adjuvants, Immunologic; BCG Vaccine; Clinical Trials as Topic; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Immunotherapy; Random Allocation; Rectal Neoplasms; Recurrence; Semustine | 1983 |
A controlled prospective trial of adjuvant razoxane in resectable colorectal cancer.
Topics: Clinical Trials as Topic; Colonic Neoplasms; Fluorouracil; Humans; Piperazines; Razoxane; Rectal Neoplasms; Recurrence; Semustine; Vincristine | 1981 |
Adjuvant chemotherapy with four drugs for stage 2 breast cancer.
Topics: Adenocarcinoma; Aged; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Random Allocation; Recurrence; Vincristine | 1980 |
Adjuvant chemotherapy, anti-estrogen therapy and immunotherapy for stage II breast cancer.
Topics: Aged; BCG Vaccine; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Random Allocation; Receptors, Estrogen; Recurrence; Tamoxifen | 1980 |
Comparison of four-combination chemotherapy programs in metastatic breast cancer: comparison of multiple drug therapy with cytoxan, 5-FU and prednisone versus cytoxan and adriamycin, versus cytoxan, 5-FU and adriamycin, versus cytoxan, 5-FU and prednisone
Topics: Adrenalectomy; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Menopause; Middle Aged; Prednisone; Random Allocation; Recurrence; Tamoxifen | 1982 |
Inefficacy of low-dose intraoperative fluorouracil in the treatment of primary pterygium.
Topics: Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Double-Blind Method; Female; Fluorouracil; Follow-Up Studies; Humans; Intraoperative Care; Male; Middle Aged; Prospective Studies; Pterygium; Recurrence | 1995 |
5-Fluorouracil, folinic acid and cisplatin in advanced colorectal cancer: a pilot study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Cisplatin; Colorectal Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Pilot Projects; Recurrence | 1995 |
Combined chemotherapy and radiotherapy for patients with breast cancer and extensive nodal involvement.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Fluorouracil; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Postoperative Care; Radiotherapy Dosage; Recurrence; Retrospective Studies; Time Factors | 1995 |
A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Staging; Radiotherapy; Radiotherapy Dosage; Recurrence; Survival Analysis; Time Factors; Tracheostomy | 1993 |
Adjuvant chemotherapy after gastric resection in node-positive cancer patients: a multicentre randomised study.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule; Epirubicin; Fluorouracil; Follow-Up Studies; Gastrectomy; Humans; Leucovorin; Lymphatic Metastasis; Neoplasm Staging; Proportional Hazards Models; Recurrence; Stomach Neoplasms; Survival Rate; Time Factors | 1996 |
Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Leucovorin; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Middle Aged; Phenotype; Prednisone; Prospective Studies; Recurrence; Survival Rate; Vincristine | 1996 |
Phase II study of chemoradiotherapy for advanced squamous cell carcinoma of the thoracic esophagus: nine Japanese institutions trial.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Quality of Life; Radiotherapy, Adjuvant; Recurrence | 1996 |
Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumor.
Topics: Adult; Aged; Antidotes; Antimetabolites, Antineoplastic; Astrocytoma; Brain Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Leukopenia; Male; Middle Aged; Oligodendroglioma; Recurrence; Stomatitis; Thrombocytopenia | 1996 |
Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer.
Topics: Adult; Aged; Aged, 80 and over; Antidotes; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Prospective Studies; Recurrence; Risk Factors | 1997 |
Intralesional fluorouracil/epinephrine injectable gel for treatment of condylomata acuminata. A phase 3 clinical study.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Condylomata Acuminata; Double-Blind Method; Epinephrine; Female; Fluorouracil; Follow-Up Studies; Gels; Genital Diseases, Female; Genital Diseases, Male; Humans; Injections, Intralesional; Male; Middle Aged; Recurrence | 1997 |
The role of radiotherapy in the management of operable locally advanced breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Fluoxymesterone; Follow-Up Studies; Humans; Mastectomy; Middle Aged; Recurrence; Survival Analysis; Tamoxifen | 1997 |
Significance of the preoperative intravesical instillation of doxorubicin and the oral administration of 5-fluorouracil in preventing recurrence after a transurethral resection of superficial bladder cancer. Kyushu University Urological Oncology Group.
Topics: Administration, Intravesical; Administration, Oral; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Treatment Outcome; Urinary Bladder Neoplasms | 1997 |
Relationship of genital wart burden to therapeutic response to fluorouracil/epinephrine injectable gel.
Topics: Body Surface Area; Condylomata Acuminata; Drug Therapy, Combination; Epinephrine; Female; Fluorouracil; Follow-Up Studies; Gels; Humans; Immunosuppressive Agents; Injections, Intradermal; Injections, Intralesional; Male; Recurrence; Treatment Outcome; Vasoconstrictor Agents | 1997 |
High-dose chemotherapy consolidation with autologous stem cell rescue in metastatic breast cancer: a 10-year experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Methotrexate; Middle Aged; Mitoxantrone; Recurrence; Survival Rate; Thiotepa; Time Factors; Transplantation, Autologous; Vincristine | 1998 |
Advanced nasopharyngeal carcinoma treated with chemotherapy and radiotherapy: distant metastasis and local recurrence.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Recurrence; Survival Rate; Time Factors | 1998 |
Development of intralesional therapy with fluorouracil/adrenaline injectable gel for management of condylomata acuminata: two phase II clinical studies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Condylomata Acuminata; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Epinephrine; Female; Fluorouracil; Gels; Humans; Injections, Intralesional; Male; Middle Aged; Recurrence; Treatment Outcome | 1997 |
A phase II trial of low dose administration of 5-fluorouracil and cisplatin in patients with advanced and recurrent gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Staging; Quality of Life; Recurrence; Stomach Neoplasms; Survival Analysis; Time Factors | 1999 |
Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Recurrence; Survival Rate; Tamoxifen; Vincristine | 1999 |
Irinotecan (CPT-11) in patients with advanced colorectal cancer previously treated with 5-fluorouracil-based chemotherapy.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorouracil; Humans; Irinotecan; Male; Middle Aged; Recurrence; Survival Rate; Treatment Outcome | 1999 |
Combination chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in previously treated patients with advanced/recurrent head and neck cancer: a phase II feasibility study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease Progression; Disease-Free Survival; Docetaxel; Feasibility Studies; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neutropenia; Paclitaxel; Recurrence; Taxoids | 2000 |
Concomitant chemoradiation treatment in the management of patients with extrahepatic biliary tract recurrence of gastric carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Brachytherapy; Cholestasis, Extrahepatic; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Palliative Care; Recurrence; Stomach Neoplasms; Treatment Outcome | 2000 |
Halting pterygium recurrence by postoperative 5-fluorouracil.
Topics: Adult; Aged; Drug Evaluation; Female; Fluorouracil; Humans; Immunosuppressive Agents; Injections, Intralesional; Male; Middle Aged; Pilot Projects; Postoperative Care; Pterygium; Recurrence | 2001 |
Monthly 5-days 5-fluorouracil and low-dose leucovorin for adjuvant chemotherapy in colon cancer.
Topics: Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Recurrence; Survival Analysis | 2001 |
Improved survival after one course of perioperative chemotherapy in early breast cancer patients. long-term results from the European Organization for Research and Treatment of Cancer (EORTC) Trial 10854.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy; Middle Aged; Neoplasm Proteins; Premenopause; Receptors, Estrogen; Recurrence; Survival Rate | 2001 |
[Capecitabine (xeloda) in the treatment of relapsed and metastatic breast cancer].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Deoxycytidine; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Recurrence | 2002 |
Five-year follow-up results of a collaborative study of therapies for carcinoma of the bladder.
Topics: Clinical Trials as Topic; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Recurrence; Time Factors; Urinary Bladder Neoplasms | 1977 |
Adjuvant chemotherapy in the primary management of breast cancer.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Division; Cell Survival; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mammary Neoplasms, Experimental; Melphalan; Methotrexate; Middle Aged; Neoplasm Metastasis; Recurrence; Research Design | 1977 |
Surgery and adjuvant chemotherapy in the treatment of operable breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Recurrence | 1977 |
[Treatment of acute pancreatitis].
Topics: Acute Disease; Adolescent; Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Female; Fluorouracil; Humans; Male; Middle Aged; Pancreatectomy; Pancreatitis; Recurrence; Tegafur | 1979 |
Adjuvant chemotherapy in breast cancer--Swiss co-operative studies.
Topics: Antineoplastic Agents; BCG Vaccine; Breast Neoplasms; Chlorambucil; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Prednisone; Recurrence; Time Factors | 1979 |
[Controlled clinical studies of a new wart medication based on fluorouracil].
Topics: Adolescent; Adult; Aged; Baths; Child; Child, Preschool; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Fluorouracil; Humans; Male; Middle Aged; Placebos; Recurrence; Skin Diseases; Sodium Chloride; Warts | 1979 |
5-Fluorouracil as adjuvant chemotherapy for large bowel cancer. Is it appropriate for routine community use?
Topics: BCG Vaccine; Clinical Trials as Topic; Fluorouracil; Humans; Intestinal Neoplasms; Neoplasm Metastasis; Recurrence | 1979 |
Chemotherapy as an adjuvant to surgery for colorectal cancer.
Topics: Adenocarcinoma; Administration, Oral; Colonic Neoplasms; Fluorouracil; Humans; Postoperative Care; Postoperative Complications; Prospective Studies; Rectal Neoplasms; Recurrence; Sodium Chloride | 1975 |
Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Recurrence; Vulvar Neoplasms | 1992 |
5-fluorouracil and low-dose leucovorin in the treatment of recurrent epithelial ovarian carcinoma. A phase II trial of the Gynecologic Oncology Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Female; Fluorouracil; Humans; Leucovorin; Middle Aged; Ovarian Neoplasms; Recurrence | 1992 |
5-fluorouracil and low-dose leucovorin in the treatment of recurrent squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Leucovorin; Middle Aged; Recurrence; Uterine Cervical Neoplasms | 1992 |
Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Survival Analysis; Tamoxifen | 1990 |
Adjuvant therapy for operable breast cancer with medroxyprogesterone acetate alone in postmenopausal patients or in combination with CMF in premenopausal patients.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Methotrexate; Middle Aged; Prospective Studies; Recurrence | 1988 |
Evaluation of 6,17 alpha-dimethyl-6-dehydroprogesterone for treatment of recurrent and metastatic gynecologic malignancy.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Clinical Trials as Topic; Cyclophosphamide; Drug Synergism; Drug Therapy, Combination; Female; Fluorouracil; Genital Neoplasms, Female; Humans; Medrogestone; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Parity; Pregnadienes; Progesterone; Progestins; Recurrence; Sarcoma; Uterine Cervical Neoplasms; Uterine Neoplasms | 1974 |
228 other study(ies) available for fluorouracil and Recrudescence
| Article | Year |
|---|---|
[A Case Report for Peritoneal Recurrences by Laparoscopic Surgery after Colorectal Cancer Resection].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Colonic Neoplasms; Colorectal Neoplasms; Female; Fluorouracil; Humans; Laparoscopy; Leucovorin; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Recurrence; Tegafur | 2022 |
Contour first-retrospective study of an algorithmic approach of auricular keloids.
Topics: Ear Auricle; Ear, External; Fluorouracil; Humans; Keloid; Recurrence; Retrospective Studies; Treatment Outcome | 2023 |
Incidence of Disease Recurrence in Patients With Colon and Upper Rectum Adenocarcinoma Stage II and III Receiving Adjuvant Capecitabine Monotherapy: Do Number of Chemotherapy Cycles and Relative Dose Intensity of the Drug Play a Role?
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colon; Fluorouracil; Humans; Incidence; Neoplasm Staging; Rectal Neoplasms; Rectum; Recurrence | 2023 |
Successful non-operative treatment of eruptive keratoacanthomas refractory to excision.
Topics: Aged; Antimetabolites, Antineoplastic; Arm; Fluorouracil; Humans; Injections, Intralesional; Keratoacanthoma; Male; Recurrence | 2020 |
5-Fluorouracil Is Associated With a Decreased Recurrence Risk in Odontogenic Keratocyst Management: A Retrospective Cohort Study.
Topics: Fluorouracil; Humans; Neoplasm Recurrence, Local; Odontogenic Cysts; Odontogenic Tumors; Recurrence; Retrospective Studies | 2021 |
Botulinum toxin type-A versus 5-fluorouracil in the treatment of plaque psoriasis: Comparative study.
Topics: Botulinum Toxins, Type A; Fluorouracil; Humans; Psoriasis; Recurrence; Treatment Outcome | 2021 |
Acute Disseminated Intravascular Coagulation after Oxaliplatin Infusion.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Creatinine; Disseminated Intravascular Coagulation; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Male; Organoplatinum Compounds; Oxaliplatin; Recurrence | 2017 |
[A Case of Bilateral Lymph Node Metastases of Rectal Cancer Treated with Chemotherapy and Surgery].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Combined Modality Therapy; Fluorouracil; Humans; Laparoscopy; Leucovorin; Lymphatic Metastasis; Male; Organoplatinum Compounds; Rectal Neoplasms; Recurrence | 2017 |
Ocular surface changes in recurrent pterygium cases post-operatively treated with 5-fluorouracil subconjunctival injections.
Topics: Adult; Antimetabolites; Conjunctiva; Cornea; Epithelial Cells; Female; Fluorouracil; Follow-Up Studies; Goblet Cells; Humans; Injections, Intralesional; Male; Metaplasia; Middle Aged; Postoperative Complications; Pterygium; Recurrence; Retrospective Studies | 2019 |
Toxicity, Tolerability, and Compliance of Concurrent Capecitabine or 5-Fluorouracil in Radical Management of Anal Cancer With Single-dose Mitomycin-C and Intensity Modulated Radiation Therapy: Evaluation of a National Cohort.
Topics: Adenocarcinoma; Aged; Anus Neoplasms; Capecitabine; Carcinoma, Squamous Cell; Chemoradiotherapy; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Patient Compliance; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Recurrence; Treatment Outcome; United Kingdom | 2018 |
[A Case Describing Treatment with FOLFIRI plus Bevacizumab after a Self-Expandable Metallic Stent Placement for Local Recurrence].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Fluorouracil; Humans; Intestinal Obstruction; Leucovorin; Male; Middle Aged; Rectal Neoplasms; Recurrence; Self Expandable Metallic Stents; Sigmoid Neoplasms | 2018 |
Functional significance of Hippo/YAP signaling for drug resistance in colorectal cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Cell Cycle Proteins; Cell Line, Tumor; Colorectal Neoplasms; Drug Resistance, Neoplasm; Fluorouracil; Gene Knockout Techniques; Hippo Signaling Pathway; Humans; Kaplan-Meier Estimate; Mice; Nuclear Proteins; Prognosis; Protein Serine-Threonine Kinases; Recurrence; RNA, Small Interfering; Signal Transduction; Transcription Factors | 2018 |
Adjuvant Chemotherapy in Rectal Cancer Patients Treated With Preoperative Chemoradiation and Total Mesorectal Excision: A Multicenter and Retrospective Propensity-Score Matching Study.
Topics: Aged; Capecitabine; Chemoradiotherapy; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Oxaliplatin; Propensity Score; Rectal Neoplasms; Recurrence; Retrospective Studies; Treatment Outcome | 2019 |
Analysis of Keloid Response to 5-Fluorouracil Treatment and Long-Term Prevention of Keloid Recurrence.
Topics: Adaptor Proteins, Signal Transducing; Biopsy; Chemokine CCL2; Dermis; Fluorouracil; Follow-Up Studies; Gene Expression Profiling; Humans; Injections, Intralesional; Keloid; Phosphoproteins; Recurrence; Transcription Factors; Treatment Outcome; YAP-Signaling Proteins | 2019 |
Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplastic Cells, Circulating; Organoplatinum Compounds; Prognosis; Recurrence; Treatment Outcome | 2013 |
Cisplatin plus capecitabine as first-line chemotherapy for recurrent or metastatic head and neck squamous cell cancer: experience outside of a trial setting.
Topics: Adult; Aged; Antineoplastic Agents; Capecitabine; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Drug Therapy, Combination; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neutropenia; Recurrence; Retrospective Studies | 2013 |
Hepatoid adenocarcinoma of the stomach: an unusual case of elevated alpha-fetoprotein with prior treatment for hepatocellular carcinoma.
Topics: Adenocarcinoma; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Fluorouracil; Gastroscopy; Humans; Leucovorin; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Recurrence; Silicates; Stomach Neoplasms; Titanium; Tomography, X-Ray Computed | 2013 |
[A case of recurrent colon cancer developed thrombosis in superior mesenteric vein after chemotherapy].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Colonic Neoplasms; Fibrinolytic Agents; Fluorouracil; Humans; Leucovorin; Male; Mesenteric Veins; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Recurrence; Urokinase-Type Plasminogen Activator; Venous Thrombosis | 2013 |
[A case of necrotizing fasciitis developed in a patient with recurrent rectal cancer treated with chemotherapy].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Combined Modality Therapy; Deoxycytidine; Fasciitis, Necrotizing; Fatal Outcome; Female; Fluorouracil; Humans; Middle Aged; Oxaloacetates; Rectal Neoplasms; Recurrence | 2013 |
[A case of hyperammonemic encephalopathy related to 5-FU in an aged patient with recurrent colon cancer treated with FOLFIRI therapy].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Brain Diseases, Metabolic; Camptothecin; Combined Modality Therapy; Fluorouracil; Humans; Hyperammonemia; Leucovorin; Male; Recurrence | 2013 |
[Combined therapy of lapatinib and capecitabine effective against local recurrence of breast cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Carcinoma, Intraductal, Noninfiltrating; Deoxycytidine; Female; Fluorouracil; Humans; Lapatinib; Quinazolines; Recurrence; Tomography, X-Ray Computed | 2013 |
Thymidylate synthase gene polymorphism and survival of colorectal cancer patients receiving adjuvant 5-fluorouracil.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Chemotherapy, Adjuvant; Colorectal Neoplasms; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Poland; Polymorphism, Genetic; Recurrence; Survival Analysis; Thymidylate Synthase | 2013 |
Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Paclitaxel; Prognosis; Recurrence; Survival Analysis; Taxoids | 2013 |
A curious case of oxaliplatin-induced neurotoxicity: recurrent, self-limiting dysarthria.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Administration Schedule; Dysarthria; Fluorouracil; Humans; Irinotecan; Leucovorin; Male; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Recurrence; Time Factors | 2014 |
Serial sub-conjunctival 5-Fluorouracil for early recurrent anophthalmic contracted socket.
Topics: Adult; Anophthalmos; Antimetabolites; Conjunctiva; Contracture; Eye Enucleation; Eye, Artificial; Fluorouracil; Humans; Injections, Intraocular; Orbital Diseases; Orbital Implants; Plastic Surgery Procedures; Postoperative Period; Recurrence; Retrospective Studies | 2013 |
Timeliness of adjuvant chemotherapy for stage III adenocarcinoma of the colon: a measure of quality of care.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Recurrence; Retrospective Studies; Risk Factors; Time Factors | 2013 |
Association of single nucleotide polymorphisms in MTHFR and ABCG2 with the different efficacy of first-line chemotherapy in metastatic colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Camptothecin; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Genotype; Humans; Leucovorin; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Proteins; Organoplatinum Compounds; Oxaloacetates; Pharmacogenetics; Polymorphism, Single Nucleotide; Recurrence; Retrospective Studies | 2014 |
[A case of recurrent duodenal carcinoma successfully controlled with FOLFOX treatment].
Topics: Antineoplastic Combined Chemotherapy Protocols; Duodenal Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Organoplatinum Compounds; Recurrence | 2013 |
[Recurrent rectal cancer with multiple liver and lung metastases treated effectively with oxaliplatin and capecitabine plus bevacizumab chemotherapy-a case report].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Deoxycytidine; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Organoplatinum Compounds; Oxaliplatin; Recurrence; Sigmoid Neoplasms | 2013 |
[A case of successful radical resection of rectal cancer with neo-adjuvant chemoradiotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Rectal Neoplasms; Recurrence; Treatment Outcome | 2013 |
[A case in which chemotherapy-resistant sigmoid colon cancer was controlled effectively by radiotherapy and resection].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Combined Modality Therapy; Deoxycytidine; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Oxaloacetates; Recurrence; Sigmoid Neoplasms | 2013 |
[A case of recurrent rectal cancer successfully treated for a long period with capecitabine plus oxaliplatin and bevacizumab therapy].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Deoxycytidine; Female; Fluorouracil; Humans; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Recurrence; Remission Induction; Sigmoid Neoplasms; Time Factors | 2013 |
[A case of a recurrent hepatic metastasis occurred after curative resection of ascending colon cancer and a hepatic metastasis responding completely to capecitabine plus bevacizumab].
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Chemotherapy, Adjuvant; Colectomy; Colon, Ascending; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Liver Neoplasms; Male; Recurrence | 2013 |
[Protocol for the administration of modified FOLFOX6 (mFOLFOX6) in patients with unresectable/recurrent colorectal cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Prognosis; Quality of Life; Recurrence | 2013 |
[Recurrent gastric cancer treated with fourth-line chemotherapy consisting of capecitabine and cisplatin leading to partial response].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Fluorouracil; Humans; Male; Neoplasm Staging; Recurrence; Salvage Therapy; Stomach Neoplasms | 2013 |
[Multidisciplinary therapy for 3 patients with lymph node recurrence after curative gastrectomy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Gastrectomy; Humans; Irinotecan; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Recurrence; Stomach Neoplasms | 2013 |
[A retrospective study of tegafur/uracil compared with cyclophosphamide, methotrexate, and fluorouracil as adjuvant chemotherapy in patients with node-negative, triple-negative breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Tegafur; Triple Negative Breast Neoplasms; Uracil | 2014 |
[A case of primary duodenal cancer recurrence successfully treated with CapeOX therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Duodenal Neoplasms; Fatal Outcome; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Pancreaticoduodenectomy; Peritoneal Neoplasms; Recurrence | 2014 |
[Retrospective analysis of the bevacizumab and CapeOX combination in untreated metastatic/recurrent colorectal cancer].
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Recurrence; Retrospective Studies; Treatment Outcome | 2014 |
[A case of esophageal squamous cell carcinoma with an adenocarcinoma component that dedifferentiated after chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Differentiation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorouracil; Humans; Liver Neoplasms; Male; Organoplatinum Compounds; Recurrence | 2014 |
Omega-3 fatty acid is a potential preventive agent for recurrent colon cancer.
Topics: Animals; Anticarcinogenic Agents; beta Catenin; Biomarkers, Tumor; Cell Line, Tumor; Colon; Colonic Neoplasms; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Fluorouracil; Humans; Inflammation; Mice; Mice, SCID; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Organoplatinum Compounds; Oxaliplatin; Phenotype; Recurrence; Xenograft Model Antitumor Assays | 2014 |
Modified administration schedule of docetaxel, cisplatin, and fluorouracil for advanced or recurrent gastric cancer with gastrointestinal stenosis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Gastric Outlet Obstruction; Gastrointestinal Diseases; Humans; Intestinal Obstruction; Male; Middle Aged; Recurrence; Stomach Neoplasms; Taxoids | 2014 |
[Systemic chemotherapy and surgery for recurrent metachronous liver metastases with peritoneal dissemination from triple colon cancers-a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Fluorouracil; Hepatectomy; Humans; Liver Neoplasms; Male; Neoplasms, Multiple Primary; Oxaloacetates; Peritoneal Neoplasms; Recurrence | 2014 |
Irinotecan and capecitabine combination chemotherapy in a patient with triple-negative breast cancer relapsed after adjuvant chemotherapy with anthracycline and taxane.
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Camptothecin; Capecitabine; Chemoradiotherapy; Chemotherapy, Adjuvant; Deoxycytidine; Drug Administration Schedule; Female; Fluorouracil; Humans; Irinotecan; Magnetic Resonance Imaging; Middle Aged; Pelvic Bones; Positron-Emission Tomography; Recurrence; Taxoids; Tomography, X-Ray Computed; Treatment Failure; Treatment Outcome; Triple Negative Breast Neoplasms | 2015 |
[A case report of the use of laparoscopic surgery to remove an adrenal tumor following resection of sigmoid colon cancer].
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine; Female; Fluorouracil; Humans; Laparoscopy; Middle Aged; Multimodal Imaging; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Recurrence; Sigmoid Neoplasms; Tomography, X-Ray Computed | 2014 |
[Irradiation with carbon ions for locally recurrent rectal cancer].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Heavy Ion Radiotherapy; Humans; Leucovorin; Neoplasm Staging; Organoplatinum Compounds; Pelvic Neoplasms; Rectal Neoplasms; Recurrence | 2014 |
[A case of metastatic gastric cancer originating from transverse colon cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colon, Transverse; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Lymphatic Metastasis; Middle Aged; Oxaloacetates; Peritoneal Neoplasms; Recurrence; Stomach Neoplasms | 2014 |
[A case of gastric cancer showing response to first-line XP regimen after lymph node recurrence during the administration of S-1 as postoperative adjuvant chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Drug Combinations; Female; Fluorouracil; Humans; Lymphatic Metastasis; Oxonic Acid; Recurrence; Salvage Therapy; Stomach Neoplasms; Tegafur | 2014 |
A cost-utility analysis of ingenol mebutate gel for the treatment of actinic keratosis: a Scottish perspective.
Topics: Cost-Benefit Analysis; Cryotherapy; Diclofenac; Diterpenes; Dose-Response Relationship, Drug; Fluorouracil; Humans; Keratolytic Agents; Keratosis, Actinic; Models, Econometric; Quality-Adjusted Life Years; Recurrence; Salicylic Acid; Scotland; Treatment Outcome | 2016 |
Tumor recurrence and in-field control after multimodality treatment of locally advanced esophageal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Recurrence | 2015 |
[5-FU+CDDP(FP) +cetuximab in recurrence/metastasis head and neck cancer].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Cisplatin; Fluorouracil; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Recurrence | 2015 |
[A Case of Concurrent Cancer in a Giant Rectal Villous Adenoma That Resulted in Extensive Lymph Node Metastases].
Topics: Adenoma, Villous; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine; Fluorouracil; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Oxaloacetates; Rectal Neoplasms; Recurrence | 2015 |
[A Case of Early Recurrence after Esophagectomy for Cancer Following Neoadjuvant Chemotherapy Resulting in a Complete Response of the Primary Lesion].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Esophageal Neoplasms; Esophagectomy; Fatal Outcome; Fluorouracil; Humans; Male; Neoadjuvant Therapy; Organoplatinum Compounds; Recurrence; Time Factors | 2015 |
[Long-Term Successful Management of Recurrent Rectal Cancer in the Predialysis State with FOLFIRI Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Dialysis; Fatal Outcome; Fluorouracil; Humans; Leucovorin; Male; Organoplatinum Compounds; Rectal Neoplasms; Recurrence; Renal Insufficiency, Chronic; Time Factors | 2015 |
[Para-Aortic Lymphadenectomy and Subsequent Chemotherapy after Resection of the Primary Lesion for Poorly Differentiated Adenocarcinoma of the Sigmoid Colon - A Case Report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Chemotherapy, Adjuvant; Fluorouracil; Humans; Leucovorin; Lymph Node Excision; Male; Organoplatinum Compounds; Recurrence; Sigmoid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
[Impact of platelet count on prognosis of stage II-III colorectal cancer receiving adjuvant chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Colorectal Neoplasms; Disease-Free Survival; Fluorouracil; Humans; Leucovorin; Neoplasm Staging; Organoplatinum Compounds; Platelet Count; Prognosis; Recurrence; Retrospective Studies | 2015 |
[A Case of Salvage Chemoradiotherapy for Regional Recurrence after Curative Esophagectomy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Lymphatic Metastasis; Recurrence; Salvage Therapy; Treatment Outcome | 2015 |
[XELOX plus Bevacizumab Chemotherapy for a Patient with Postoperative Recurrence of Colorectal Cancer Under Hemodialysis for Chronic Renal Failure].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colectomy; Combined Modality Therapy; Deoxycytidine; Fluorouracil; Hepatectomy; Humans; Kidney Failure, Chronic; Liver Neoplasms; Male; Oxaloacetates; Recurrence; Renal Dialysis; Sigmoid Neoplasms | 2015 |
[Successful Resection of the Peritoneal Dissemination Recurrence of Colon Cancer, Including Metastasis to the Inguinal Hernia Sac--A Case Report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Colonic Neoplasms; Fluorouracil; Hernia, Inguinal; Humans; Leucovorin; Male; Organoplatinum Compounds; Peritoneal Neoplasms; Recurrence | 2015 |
[A Patient with Recurrent Ulcerative Colitis-Associated Rectal Cancer Attaining a Complete Response with FOLFIRI plus Bevacizumab].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Colitis, Ulcerative; Combined Modality Therapy; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Rectal Neoplasms; Recurrence; Remission Induction | 2015 |
[Recurrence of Rectal Cancer with Submucosal Invasion in the Bone and Lymph Nodes 89 Months after Surgery--A Case Report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Camptothecin; Chemoradiotherapy; Female; Fluorouracil; Humans; Intestinal Mucosa; Leucovorin; Lymphatic Metastasis; Neoplasm Invasiveness; Neoplasm Staging; Rectal Neoplasms; Recurrence; Time Factors | 2015 |
[A Case of Rectal Cancer with Multiple Liver, Lung, and Para-Aortic Lymph Node Metastases Successfully Treated with FOLFOX4 plus Bevacizumab].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Bevacizumab; Chemotherapy, Adjuvant; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Organoplatinum Compounds; Rectal Neoplasms; Recurrence | 2015 |
[A Case of Thrombotic Thrombocytopenic Purpura in a Patient Undergoing FOLFOX6 plus Panitumumab Therapy for Unresectable Recurrent Rectal Cancer with a Rapidly Progressive Course].
Topics: ADAM Proteins; ADAMTS13 Protein; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Fatal Outcome; Fluorouracil; Humans; Leucovorin; Male; Organoplatinum Compounds; Panitumumab; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Rectal Neoplasms; Recurrence | 2016 |
[Individual Dose Adjustment of 5-Fluorouracil Based on Pharmacokinetic Monitoring May Improve the Outcome of FOLFOX for Metastatic Colorectal Cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Rectal Neoplasms; Recurrence; Retrospective Studies | 2016 |
[Adjuvant Systemic Chemotherapy with S-1/Oxaliplatin or mFOLFOX6 after Curative Resection of Distant Metastases in Patients with Colorectal Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Combinations; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Rectal Neoplasms; Recurrence; Retrospective Studies; Tegafur | 2016 |
Comparison of primary versus recurrent pterygium after intralesional 5-Fluorouracil.
Topics: Adult; Astigmatism; Drug Administration Schedule; Female; Fluorouracil; Humans; Injections, Intralesional; Male; Pterygium; Recurrence | 2016 |
[A Case of Stage IV Colon Cancer Relapsed 10 Years after Curative Resection with Adjuvant Chemotherapy Using Long-Term, Low-Dose Leucovorin and 5-Fluorouracil(LV/5-FU)].
Topics: Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Middle Aged; Neoplasm Staging; Recurrence | 2016 |
HSP90 is a promising target in gemcitabine and 5-fluorouracil resistant pancreatic cancer.
Topics: Adenocarcinoma; Apoptosis; Benzoquinones; Cell Line, Tumor; Deoxycytidine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fluorouracil; Gemcitabine; HSP90 Heat-Shock Proteins; Humans; Inhibitory Concentration 50; Lactams, Macrocyclic; Molecular Targeted Therapy; Neoplasm Proteins; Pancreatic Neoplasms; Recurrence | 2017 |
[A Patient with Colon Cancer Local Site Recurrence Who Experienced Difficulty Tolerating Intensive Chemotherapy Was Treated Effectively with sLV5FU2 Therapy].
Topics: Abdominal Neoplasms; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Leucovorin; Male; Rectal Neoplasms; Recurrence; Treatment Outcome | 2016 |
[Recurrence of Jejunal Carcinoma in the Ileum and Ovary - A Case Report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colectomy; Deoxycytidine; Female; Fluorouracil; Humans; Ileal Neoplasms; Jejunal Neoplasms; Middle Aged; Ovarian Neoplasms; Ovariectomy; Oxaloacetates; Recurrence | 2016 |
[A Case of Aortoesophageal Fistula Rupture Due to Descending Thoracic Aortic Dissection with Recurrent Colon Cancer during Chemotherapy Containing Bevacizumab].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aortic Diseases; Bevacizumab; Capecitabine; Colonic Neoplasms; Deoxycytidine; Esophageal Fistula; Fatal Outcome; Female; Fluorouracil; Humans; Oxaloacetates; Postoperative Complications; Recurrence | 2016 |
[Long-Term Complete Response in Postoperative Multiple Lung and Mediastinal Lymph Node Metastases of Esophageal Cancer Using Systemic Chemotherapy with DCF Treatment - A Case Report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Esophageal Neoplasms; Esophagectomy; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Recurrence; Taxoids; Time Factors; Treatment Outcome | 2017 |
Coincidential successful treatment of Jessner-Kanof disease with chemotherapy.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphocytes; Mastectomy, Radical; Recurrence; Skin Diseases; Time Factors; Treatment Outcome | 2008 |
[Combination chemotherapy composed of mFOLFOX 6, FOLFIRI 2 and surgery and radiation therapy for locoregional recurrences and multiple lung metastases from rectal cancer--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoembryonic Antigen; Cisplatin; Combined Modality Therapy; Fluorouracil; Humans; Leucovorin; Lung Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Positron-Emission Tomography; Rectal Neoplasms; Recurrence; Tomography, X-Ray Computed | 2008 |
Four consecutive multicenter phase II trials of adjuvant chemoradiation in patients with completely resected high-risk gastric cancer: the experience of the German AIO/ARO/CAO group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Gastrectomy; Germany; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Staging; Recurrence; Stomach Neoplasms; Treatment Outcome | 2009 |
Expression profiling identifies genes that predict recurrence of breast cancer after adjuvant CMF-based chemotherapy.
Topics: Adaptor Proteins, Vesicular Transport; Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Chemokine CXCL9; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; GTP-Binding Protein alpha Subunit, Gi2; Histones; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mastectomy; Methotrexate; Middle Aged; Neoplasm Proteins; Oligonucleotide Array Sequence Analysis; Recurrence; RNA, Messenger; RNA, Neoplasm | 2009 |
[A case of esophageal cancer with recurrent lymph-node metastasis successfully treated with chemo-radiotherapy after mediastinoscopy-assisted transhiatal esophagectomy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; Fluorouracil; Humans; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Organoplatinum Compounds; Recurrence; Remission Induction; Tomography, X-Ray Computed | 2008 |
[A case of ascending colon cancer with local recurrence responding completely to alternating modified-FOLFOX6 and FOLFIRI regimens(modified-FIREFOX regimen)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Colonic Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Middle Aged; Organoplatinum Compounds; Positron-Emission Tomography; Recurrence; Remission Induction; Tomography, X-Ray Computed | 2009 |
[A long-term recurrence-free survivor after chemotherapy with 5-FU plus CDDP and surgery for small cell carcinoma of the esophagus].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Small Cell; Cisplatin; Esophageal Neoplasms; Esophagoscopy; Fluorouracil; Humans; Male; Middle Aged; Radiography; Recurrence; Remission Induction; Survivors | 2009 |
Neoadjuvant 5 fluorouracil-cisplatin chemoradiation effect on survival in patients with resectable pancreatic head adenocarcinoma: a ten-year single institution experience.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Fluorouracil; Follow-Up Studies; Humans; Neoadjuvant Therapy; Pancreas; Pancreatic Neoplasms; Recurrence; Time Factors; Treatment Outcome | 2009 |
[A case of hyperammonemic encephalopathy in a patient with recurrent colon cancer treated with modified FOLFOX6].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases, Metabolic; Colonic Neoplasms; Female; Fluorouracil; Humans; Hyperammonemia; Leucovorin; Organoplatinum Compounds; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2009 |
Complete pathologic response after preoperative rectal cancer chemoradiotherapy.
Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Radiotherapy Dosage; Radiotherapy, Adjuvant; Rectal Neoplasms; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Case series of multiple recurrent reactive keratoacanthomas developing at surgical margins.
Topics: Acitretin; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Fluorouracil; Forearm; Humans; Injections, Intralesional; Keratoacanthoma; Keratolytic Agents; Male; Methotrexate; Recurrence; Skin Neoplasms | 2009 |
[A case of liver metastasis of rectal cancer, refractory to previous chemotherapy(5-FU/LV, irinotecan, oxaliplatin) responding to bevacizumab combined with FOLFIRI chemotherapy].
Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Quality of Life; Rectal Neoplasms; Recurrence; Salvage Therapy | 2009 |
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Clinical Trials, Phase III as Topic; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genetic Testing; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Patient Selection; Postmenopause; Predictive Value of Tests; Proportional Hazards Models; Randomized Controlled Trials as Topic; Receptors, Estrogen; Recurrence; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Risk Assessment; Tamoxifen; Time Factors; Treatment Outcome; United States | 2010 |
First-generation genomic tests for breast cancer treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genetic Testing; Humans; Lymphatic Metastasis; Predictive Value of Tests; Receptors, Estrogen; Recurrence; Tamoxifen; Time Factors; Treatment Outcome | 2010 |
Weekly paclitaxel for heavily treated advanced or recurrent gastric cancer refractory to fluorouracil, irinotecan, and cisplatin.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Ascites; Camptothecin; Cisplatin; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Irinotecan; Male; Middle Aged; Paclitaxel; Recurrence; Retrospective Studies; Salvage Therapy; Stomach Neoplasms; Survival Rate; Treatment Outcome; Young Adult | 2009 |
[Oxaliplatin and leucovorin plus fluorouracil versus irinotecan and leucovorin plus fluorouracil combination chemotherapy as a first-line treatment in patients with metastatic or recurred gastric adenocarcinoma].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Recurrence; Retrospective Studies; Stomach Neoplasms; Survival Analysis | 2010 |
Influence of thymidylate synthase DNA polymorphisms and gender on the clinical evolution of patients with advanced colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chi-Square Distribution; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorouracil; Gene Frequency; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Minisatellite Repeats; Polymorphism, Single Nucleotide; Proportional Hazards Models; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; Sex Factors; Thymidylate Synthase; Time Factors; Treatment Outcome | 2010 |
Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer.
Topics: Aged; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Cell Proliferation; Chemotherapy, Adjuvant; Cohort Studies; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Italy; Korea; Male; MicroRNAs; Middle Aged; Multivariate Analysis; Oligonucleotide Array Sequence Analysis; Pancreatic Neoplasms; Proportional Hazards Models; Recurrence; Reproducibility of Results; Treatment Outcome | 2010 |
[Elderly patient with recurrent rectal cancer successfully responded to modified FOLFOX6 chemotherapy with bevacizumab--a case report].
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Female; Fluorouracil; Humans; Leucovorin; Organoplatinum Compounds; Rectal Neoplasms; Recurrence; Tomography, X-Ray Computed | 2010 |
[A recurrence after surgery for colon cancer with metastases of the liver and periaortic lymph nodes, with CR achieved by using bevacizumab+mFOLFOX6].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Aorta; Bevacizumab; Colonic Neoplasms; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Lymphatic Metastasis; Male; Organoplatinum Compounds; Recurrence; Tomography, X-Ray Computed | 2010 |
Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Gene Expression Profiling; Humans; Leucovorin; Recurrence; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Treatment of colorectal cancer with unresectable synchronous liver-only metastases with combined therapeutic modalities.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Catheter Ablation; Colorectal Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Proportional Hazards Models; Recurrence; Survival Rate; Treatment Outcome | 2011 |
Effect of S-1 adjuvant chemotherapy on survival following recurrence and efficacy of first-line treatment in recurrent gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Combinations; Female; Fluorouracil; Gastrectomy; Humans; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Recurrence; Retrospective Studies; Stomach Neoplasms; Tegafur; Treatment Outcome | 2010 |
Increasing nodal ratio is a poor prognostic factor for survival in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant chemotherapy: a retrospective study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Female; Fluorouracil; Gastrectomy; Humans; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Recurrence; Republic of Korea; Retrospective Studies; Risk Factors; Stomach Neoplasms; Survival Analysis | 2011 |
Whole abdominal field versus standard field radiotherapy plus concomitant and adjuvant chemotherapy for patients with locally advanced gastric cancer.
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Gastrectomy; Humans; Male; Middle Aged; Radiotherapy; Radiotherapy, Adjuvant; Recurrence; Stomach Neoplasms; Treatment Outcome | 2011 |
[Effective cetuximab monotherapy for a case of recurrence rectal cancer after multiple previous chemotherapy treatment (FOLFOX, FOLFIRI)].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cetuximab; Drug Resistance, Neoplasm; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Rectal Neoplasms; Recurrence; Salvage Therapy | 2011 |
[Prominent efficacy from capecitabine mono-therapy for a case with lymphangiosis carcinomatosa derived from recurrent breast cancer].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Deoxycytidine; Female; Fluorouracil; Humans; Lymphangitis; Middle Aged; Pleurisy; Quality of Life; Recurrence; Tomography, X-Ray Computed | 2011 |
[PSK decreased FOLFOX4-induced peripheral neuropathy and bone marrow suppression in patients with metastatic colorectal cancer].
Topics: Agaricales; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Colonic Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Peripheral Nervous System Diseases; Polysaccharides; Recurrence | 2011 |
DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.
Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; DNA Mismatch Repair; DNA-Binding Proteins; Female; Fluorouracil; Germ-Line Mutation; Humans; Male; Microsatellite Instability; Middle Aged; Multivariate Analysis; MutL Protein Homolog 1; MutS Homolog 2 Protein; Neoplasm Recurrence, Local; Neoplasm Staging; Nuclear Proteins; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Proto-Oncogene Proteins B-raf; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Survival Analysis | 2011 |
[Eighty-five-year-old patient with recurrent rectal cancer effectively treated with CapeOX chemotherapy].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Liver Neoplasms; Male; Organoplatinum Compounds; Oxaliplatin; Rectal Neoplasms; Recurrence; Tomography, X-Ray Computed | 2011 |
[Clinical significance of bolus 5-fluorouracil for recurrent or metastatic colorectal cancer treated with FOLFOX+ BevacizumabTherapy].
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Colorectal Neoplasms; Disease Progression; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Recurrence | 2011 |
[Recurrent liver sigmoid cancer responding remarkably to neoadjuvant chemotherapy using bevacizumab/XELOX: report of a case].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Liver Neoplasms; Male; Neoadjuvant Therapy; Oxaloacetates; Recurrence; Sigmoid Neoplasms; Tomography, X-Ray Computed | 2011 |
Docetaxel plus 5-fluorouracil and cisplatin (DCF) induction chemotherapy for locally advanced borderline-resectable T4 esophageal cancer.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Postoperative Complications; Recurrence; Retrospective Studies; Taxoids; Treatment Outcome | 2011 |
[FOLFOX as adjuvant chemotherapy after curative resection of distant metastatic lesions in patients with colorectal cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Recurrence; Retrospective Studies | 2011 |
[A case of recurrent rectal cancer with paraaortic lymph node metastasis treated by FOLFIRI therapy leading to complete response].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Camptothecin; Female; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Middle Aged; Rectal Neoplasms; Recurrence; Remission Induction; Tomography, X-Ray Computed | 2011 |
[Recurrance of disappearing colorectal liver metastases after mFOLFOX6 regimen].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Recurrence | 2011 |
[The clinical outcome of mFOLFOX6 treatment for colorectal cancer patients who underwent resection of liver metastasis -comparison between synchronous and metachronous liver metastasis].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Recurrence; Survival Rate; Treatment Outcome | 2011 |
[A case of colon cancer with long-term survival treated by resection of recurrence on the rectum and chemotherapy for lung metastasis].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Fluorouracil; Humans; Leucovorin; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Organoplatinum Compounds; Rectal Neoplasms; Recurrence; Sigmoid Neoplasms; Time Factors; Tomography, X-Ray Computed | 2011 |
[A case of advanced esophageal cancer invaded to the trachea with PCR after preoperative chemoradiotherapy, which relapsed at the time of three years and seven months after resection].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Esophageal Neoplasms; Fatal Outcome; Fluorouracil; Humans; Male; Neoplasm Invasiveness; Neoplasm Staging; Recurrence; Time Factors; Trachea | 2011 |
Association of Aurora-A (STK15) kinase polymorphisms with clinical outcome of esophageal cancer treated with preoperative chemoradiation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aurora Kinase A; Aurora Kinases; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Drug Resistance, Neoplasm; Esophageal Neoplasms; Female; Fluorouracil; Humans; Middle Aged; Polymorphism, Single Nucleotide; Protein Serine-Threonine Kinases; Recurrence; Treatment Outcome | 2012 |
Medial rectus Botox injection with pterygium excision and autograft as a novel technique for management of recurrent pterygium.
Topics: Aged; Antimetabolites; Botulinum Toxins, Type A; Cicatrix; Combined Modality Therapy; Conjunctiva; Fluorouracil; Humans; Injections, Intramuscular; Male; Oculomotor Muscles; Pterygium; Recurrence; Transplantation, Autologous; Visual Acuity | 2012 |
The prognostic significance of HER2 positivity for advanced gastric cancer patients undergoing first-line modified FOLFOX-6 regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Female; Fluorouracil; Genes, erbB-2; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Prognosis; Recurrence; Stomach Neoplasms; Treatment Outcome | 2012 |
[A case of rectal hemorrhage during chemotherapy with bevacizumab for local recurrence of rectal cancer].
Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Chemoradiotherapy; Deoxycytidine; Fluorouracil; Gastrointestinal Hemorrhage; Humans; Male; Oxaloacetates; Rectal Neoplasms; Recurrence | 2012 |
[A case of remnant liver metastases after resection of liver metastases from rectal cancer following treatment with 5-FU, L-OHP and CPT-11, with markedly effective treatment by cetuximab plus S-1].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cetuximab; Combined Modality Therapy; Drug Combinations; Fluorouracil; Humans; Irinotecan; Liver Neoplasms; Male; Mutation; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Rectal Neoplasms; Recurrence; Salvage Therapy; Tegafur; Tomography, X-Ray Computed | 2012 |
[Evaluation of modified OPTIMOX1 plus bevacizumab as the neoadjuvant therapy for highly advanced rectal cancers].
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Prognosis; Rectal Neoplasms; Recurrence | 2012 |
Bimonthly regimen of high-dose leucovorin, infusional 5-fluorouracil, epirubicin and cisplatin (modified ECF) as adjuvant chemotherapy in resected gastric adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Recurrence; Retrospective Studies; Stomach Neoplasms; Survival Rate | 2012 |
[A case of small intestinal cancer with peritoneal metastases treated with FOLFOX regimen].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Jejunal Neoplasms; Leucovorin; Male; Neoplasm Invasiveness; Organoplatinum Compounds; Peritoneal Neoplasms; Recurrence | 2012 |
Molecular marker identification for relapse prediction in 5-FU-based adjuvant chemotherapy in gastric and colorectal cancers.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Cell Line, Tumor; Chemotherapy, Adjuvant; Cluster Analysis; Colorectal Neoplasms; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; MAP Kinase Kinase 4; Middle Aged; Prognosis; Recurrence; RNA, Small Interfering; Stomach Neoplasms | 2012 |
A case of severe coronary spasm associated with 5-fluorouracil chemotherapy.
Topics: Aged, 80 and over; Angina Pectoris; Antineoplastic Combined Chemotherapy Protocols; Calcium Channel Blockers; Colonic Neoplasms; Coronary Angiography; Coronary Vasospasm; Drug-Eluting Stents; Electrocardiography; Fluorouracil; Humans; Leucovorin; Male; Nifedipine; Nitroglycerin; Organoplatinum Compounds; Percutaneous Coronary Intervention; Recurrence; Severity of Illness Index; Treatment Outcome; Vasodilator Agents | 2012 |
[A case of recurrent gastric cancer showing partial response to capecitabine/CDDP after treatment with S-1/CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Drug Combinations; Fluorouracil; Humans; Male; Oxonic Acid; Recurrence; Salvage Therapy; Stomach Neoplasms; Tegafur | 2012 |
Usefulness of carcinoembryonic antigen for monitoring tumor progression during palliative chemotherapy in metastatic colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-19-9 Antigen; Carcinoembryonic Antigen; Colorectal Neoplasms; Disease Progression; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Palliative Care; Predictive Value of Tests; Recurrence; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Multidrug resistance protein 2 genetic polymorphism and colorectal cancer recurrence in patients receiving adjuvant FOLFOX-4 chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Genotype; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Polymorphism, Single Nucleotide; Prognosis; Recurrence; Risk Factors; Survival Rate; Young Adult | 2013 |
[A clinical case of recurrent small intestinal cancer successfully treated with FOLFOX6].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Fluorouracil; Humans; Jejunal Neoplasms; Leucovorin; Male; Neoplasm Staging; Organoplatinum Compounds; Recurrence | 2012 |
[A case report of recurrent lung metastasis after surgery for rectal cancer for which lung radiofrequency ablation therapy and long-term administration of FOLFIRI were effective].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Catheter Ablation; Fluorouracil; Humans; Leucovorin; Lung Neoplasms; Male; Middle Aged; Rectal Neoplasms; Recurrence; Time Factors | 2012 |
A retrospective study of the safety and efficacy of a first-line treatment with modified FOLFOX-4 in unresectable advanced or recurrent gastric cancer patients.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Recurrence; Retrospective Studies; Stomach Neoplasms; Survival Rate | 2012 |
[A case of an ulcer of the sigmoid colon during chemotherapy with FOLFOX4 and bevacizumab for recurrence of rectal carcinoma].
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Female; Fluorouracil; Humans; Leucovorin; Organoplatinum Compounds; Rectal Neoplasms; Recurrence; Sigmoid Diseases; Ulcer | 2013 |
[Non-biodegradable drug-sustained capsular ring for prevention of secondary cataract. Part I: In vitro evaluation].
Topics: Biocompatible Materials; Biodegradation, Environmental; Cataract; Cataract Extraction; Delayed-Action Preparations; Fluorouracil; Humans; Methacrylates; Recurrence | 2003 |
[Nonbiodegradable drug-sustained capsular ring for prevention of secondary cataract. Part II: In vivo evaluation].
Topics: Animals; Antimetabolites; Biocompatible Materials; Capsules; Cataract; Delayed-Action Preparations; Disease Models, Animal; Fluorouracil; Phacoemulsification; Postoperative Complications; Rabbits; Recurrence; Swine; Swine, Miniature | 2003 |
5-Fluorouracil as chemoadjuvant for primary pterygium surgery: preliminary report.
Topics: Adult; Conjunctiva; Female; Fluorouracil; Humans; Injections; Intraoperative Care; Male; Middle Aged; Nucleic Acid Synthesis Inhibitors; Ophthalmologic Surgical Procedures; Postoperative Care; Pterygium; Recurrence | 2003 |
Reactivation of hepatitis C virus after chemotherapy for colon cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma; Colonic Neoplasms; Fluorouracil; Hepatitis C; Humans; Immunocompromised Host; Irinotecan; Leucovorin; Male; Recurrence | 2004 |
Combined 5-fluorouracil and Er:YAG laser treatment in a case of recurrent giant keratoacanthoma of the lower leg.
Topics: Administration, Cutaneous; Antimetabolites, Antineoplastic; Combined Modality Therapy; Diagnosis, Differential; Drug Administration Schedule; Female; Fluorouracil; Humans; Keratoacanthoma; Laser Therapy; Leg; Middle Aged; Recurrence; Skin Diseases | 2004 |
The effects of capecitabine in Raynaud's disease: a case report.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Capecitabine; Deoxycytidine; Fluorouracil; Follow-Up Studies; Humans; Male; Raynaud Disease; Rectal Neoplasms; Recurrence; Risk Assessment; Severity of Illness Index; Vasoconstriction | 2005 |
Cancer cell adaptation to chemotherapy.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biopsy; Camptothecin; Cell Line, Tumor; Cisplatin; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Drug Therapy; Epirubicin; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Irinotecan; Neoplasms; Paclitaxel; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Topotecan; Treatment Outcome; Up-Regulation | 2005 |
Pre-exenterative chemotherapy, a novel therapeutic approach for patients with persistent or recurrent cervical cancer.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Area Under Curve; Carboplatin; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Gemcitabine; Humans; Middle Aged; Neoplasm Recurrence, Local; Pelvic Exenteration; Pilot Projects; Recurrence; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2005 |
Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiotherapy; Radiotherapy Dosage; Rectal Neoplasms; Recurrence; Sex Factors; Statistics as Topic; Tegafur | 2006 |
Response of predominantly recalcitrant cutaneous warts to topical chemotherapy.
Topics: Administration, Cutaneous; Deoxyglucose; Drug Therapy, Combination; Fluorouracil; Humans; Keratolytic Agents; Levamisole; Medical Records; Minnesota; Recurrence; Retrospective Studies; Salicylic Acid; Skin Diseases; Surveys and Questionnaires; Warts | 2006 |
[Relapsing reversible posterior leukoencephalopathy after chemotherapy with cisplatin and 5-fluorouracil].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug-Related Side Effects and Adverse Reactions; Fluorouracil; Humans; Leukoencephalopathy, Progressive Multifocal; Male; Recurrence; Seizures; Stomach Neoplasms | 2006 |
A case of early relapsed multiple lung metastases after esophagectomy successfully treated with S-1/cisplatin therapy after docetaxel/5-fluorouracil/cisplatin therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Combinations; Esophageal Neoplasms; Esophagectomy; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Oxonic Acid; Recurrence; Taxoids; Tegafur | 2006 |
Successful outcome after combined chemotherapeutic and surgical management in a case of esophageal cancer with breast and brain relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Recurrence; Treatment Outcome | 2006 |
Treatment of 5-fluorouracil refractory metastatic colorectal cancer: an Australian population-based analysis.
Topics: Age Distribution; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Australia; Camptothecin; Cohort Studies; Colorectal Neoplasms; Databases, Factual; Disease Progression; Drug Resistance, Neoplasm; Drug Utilization; Female; Fluorouracil; Follow-Up Studies; Humans; Irinotecan; Male; Middle Aged; National Health Programs; Organoplatinum Compounds; Outcome Assessment, Health Care; Oxaliplatin; Practice Patterns, Physicians'; Prognosis; Randomized Controlled Trials as Topic; Recurrence; Sex Distribution; Survival Analysis | 2007 |
Failure of intracameral fluorouracil to resolve an epithelial ingrowth following clear corneal cataract surgery.
Topics: Antimetabolites; Cataract Extraction; Corneal Diseases; Epithelium, Corneal; Fluorouracil; Glaucoma, Angle-Closure; Humans; Male; Middle Aged; Postoperative Complications; Recurrence; Treatment Failure | 2007 |
Acute myelogenous leukemia following irinotecan-based chemotherapy for adenocarcinoma of the small intestine.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Fluorouracil; Humans; Intestinal Neoplasms; Intestine, Small; Irinotecan; Leucovorin; Leukemia, Myeloid, Acute; Male; Prognosis; Recurrence; Remission Induction | 2007 |
Tumour dormancy in breast cancer: an update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Neoplasm, Residual; Recurrence; Time Factors | 2007 |
Influence of thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms on the disease-free survival of breast cancer patients receiving adjuvant 5-fluorouracil/methotrexate-based therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Electrophoresis, Agar Gel; Epirubicin; Female; Fluorouracil; Genotype; Humans; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Polymerase Chain Reaction; Polymorphism, Genetic; Predictive Value of Tests; Recurrence; Retrospective Studies; Thymidylate Synthase | 2007 |
Outpatient-basis chemotherapy of oxaliplatin, 5-fluorouracil, and leucovorin as first-line treatment for patients with metastatic or recurrent colorectal cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Outpatients; Oxaliplatin; Recurrence | 2007 |
Topoisomerase I protein expression in primary colorectal cancer and recurrences after 5-FU-based adjuvant chemotherapy.
Topics: Age Factors; Chemotherapy, Adjuvant; Colorectal Neoplasms; DNA Topoisomerases, Type I; Female; Fluorouracil; Humans; Immunohistochemistry; Male; Middle Aged; Recurrence; Sex Factors | 2007 |
A renewed call for equipoise.
Topics: Adenocarcinoma; Camptothecin; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Ethics, Medical; Fluorouracil; Humans; Irinotecan; Leucovorin; Leukemia; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome; Uncertainty | 2007 |
Caspase-3 activity, response to chemotherapy and clinical outcome in patients with colon cancer.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Caspase 3; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Odds Ratio; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Recurrence; Risk Assessment; Risk Factors; Sex Factors; Time Factors; Treatment Outcome | 2008 |
[Study of the immunological mechanism of anti-tumor effects of 5-FU by establishing EL4 tumor-bearing mouse models].
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluorouracil; Lymphoma; Mice; Mice, Inbred C57BL; Recurrence; T-Lymphocytes | 2007 |
[Two advanced/recurrent breast cancer cases effectively treated by trastuzumab/capecitabine combination therapy].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Capecitabine; Deoxycytidine; Female; Fluorouracil; Humans; Immunotherapy; Liver Neoplasms; Middle Aged; Neoplasm Staging; Recurrence; Tomography, X-Ray Computed; Trastuzumab | 2008 |
[A case of triple negative recurrent breast cancer successfully treated with capecitabine+docetaxel combination chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Capecitabine; Deoxycytidine; Docetaxel; Female; Fluorouracil; Humans; Recurrence; Taxoids; Time Factors; Tomography, X-Ray Computed | 2008 |
Recurrent obstructive jaundice caused by fibrolamellar hepatocellular carcinoma.
Topics: Adult; Carcinoma, Hepatocellular; Cholestasis, Extrahepatic; Combined Modality Therapy; Doxorubicin; Fluorouracil; Humans; Liver Neoplasms; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Recurrence | 1984 |
Recurrent cervical cancer in the pelvis--intra-arterial infusion of oncostatics.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Catheterization; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Hysterectomy; Iliac Artery; Infusions, Intra-Arterial; Lymphatic Metastasis; Middle Aged; Mitomycin; Mitomycins; Pelvic Neoplasms; Peplomycin; Recurrence; Uterine Cervical Neoplasms | 1983 |
Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Hematologic Diseases; Humans; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Prednisone; Recurrence | 1984 |
[5-Fluorouracil therapy following curettage of warts].
Topics: Fluorouracil; Humans; Ointments; Postoperative Period; Recurrence; Warts | 1983 |
Recurrent acute toxic optic neuropathy secondary to 5-FU.
Topics: Female; Fluorouracil; Humans; Middle Aged; Optic Nerve Diseases; Recurrence | 1984 |
Clinical experience with irradiation of inflammatory carcinoma of the breast with and without elective chemotherapy.
Topics: Antineoplastic Agents; BCG Vaccine; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Radiotherapy, High-Energy; Recurrence; Time Factors | 1980 |
Combined treatments with vitamin A and 5-fluorouracil and the growth of allotransplantable and syngeneic tumors in mice.
Topics: Animals; Drug Therapy, Combination; Female; Fluorouracil; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Neoplasm Transplantation; Recurrence; Sarcoma 180; Time Factors; Transplantation, Homologous; Transplantation, Isogeneic; Vitamin A | 1982 |
Treatment of multiple keratoacanthomas with intralesional fluorouracil.
Topics: Fluorouracil; Humans; Keratoacanthoma; Male; Middle Aged; Recurrence; Skin Diseases | 1982 |
Chemotherapy of advanced and recurrent endometrial carcinoma with cyclophosphamide, doxorubicin, 5-fluorouracil, and megestrol acetate.
Topics: Adenocarcinoma; Age Factors; Antineoplastic Agents; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Megestrol; Recurrence; Uterine Neoplasms | 1981 |
Adjuvant therapy for stage II, estrogen receptor negative breast cancer.
Topics: Actuarial Analysis; Antineoplastic Agents; Axilla; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Receptors, Estrogen; Recurrence | 1981 |
Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Breast Neoplasms; Carcinoma; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Immunohistochemistry; Keratins; Lymphatic Metastasis; Methotrexate; Middle Aged; Postmenopause; Premenopause; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Recurrence; Survival Analysis; Tamoxifen; Time Factors | 1994 |
Changes in Tc-99m radionuclide bone scan images and peripheralization of marrow hematopoietic activity associated with the administration of granulocyte colony stimulating factor as an adjunct to dose-intensified chemotherapy for breast cancer. A case rep
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Doxorubicin; Fatal Outcome; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cells; Humans; Methotrexate; Radionuclide Imaging; Recurrence; Technetium | 1994 |
Subclinical cervicovaginal human papillomavirus infections associated with cervical condylomata and dysplasia. Treatment outcomes.
Topics: Adolescent; Adult; Condylomata Acuminata; Female; Fluorouracil; Genital Diseases, Female; Humans; Laser Therapy; Middle Aged; Papillomaviridae; Papillomavirus Infections; Recurrence; Treatment Outcome; Trichloroacetic Acid; Uterine Cervical Dysplasia | 1994 |
Cox regression analysis of multivariate failure time data: the marginal approach.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bias; Clinical Trials as Topic; Cluster Analysis; Colonic Neoplasms; Diabetic Retinopathy; Female; Fluorouracil; Humans; Infections; Levamisole; Longitudinal Studies; Male; Markov Chains; Monte Carlo Method; Multivariate Analysis; Prognosis; Proportional Hazards Models; Recurrence; Schizophrenia; Software | 1994 |
Treatment of actinic keratoses. "Life in the fast lane".
Topics: Carcinoma, Squamous Cell; Fluorouracil; Humans; Keratosis; Neoplasms, Radiation-Induced; Recurrence; Skin Neoplasms; Sunlight | 1995 |
Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment Group.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Leucovorin; Male; Middle Aged; Recurrence; Survival Analysis; Treatment Outcome | 1994 |
PS2 in breast cancer--alternative or complementary tool to steroid receptor status? Evaluation of 446 cases.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cathepsin D; Chemotherapy, Adjuvant; Cyclophosphamide; Estrogens; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Prognosis; Proteins; Radioimmunoassay; Receptors, Estrogen; Receptors, Progesterone; Recurrence; Survival Analysis; Tamoxifen; Time Factors; Trefoil Factor-1; Tumor Suppressor Proteins | 1993 |
Bowel rest, intravenous hydration, and continuous high-dose infusion of octreotide acetate for the treatment of chemotherapy-induced diarrhea in patients with colorectal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Diarrhea; Female; Fluid Therapy; Fluorouracil; Humans; Infusions, Intravenous; Intestines; Leucovorin; Male; Middle Aged; Octreotide; Prospective Studies; Rectal Neoplasms; Recurrence; Remission Induction; Time Factors | 1993 |
Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Prospective Studies; Radiotherapy; Recurrence; Remission Induction; Survival Analysis; Treatment Outcome | 1993 |
Exacerbation of rheumatoid arthritis after termination of chemotherapy for breast carcinoma.
Topics: Adenocarcinoma; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Recurrence | 1996 |
Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin.
Topics: Abdomen; Adult; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Chemotherapy, Adjuvant; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Neoplasm Seeding; Peritoneal Neoplasms; Pleura; Pseudomyxoma Peritonei; Recurrence; Sutures | 1996 |
New approaches to the management and treatment of malignant pericardial effusion.
Topics: Adult; Aged; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carbon Dioxide; Catheterization; Cisplatin; Echocardiography; Female; Fluorouracil; Hemorrhage; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Neoplasms; Oxygen; Pericardial Effusion; Pericarditis; Punctures; Recurrence; Remission Induction; Tetracycline; Ultrasonography, Interventional | 1997 |
Angiogenesis and stromal fibronectin expression in invasive breast carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fibronectins; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Microcirculation; Middle Aged; Mitomycin; Neoplasm Invasiveness; Neoplasm Staging; Neovascularization, Pathologic; Predictive Value of Tests; Prednisolone; Receptors, Estrogen; Recurrence; Regression Analysis; Stromal Cells; Time Factors | 1998 |
Reinduction therapy with the same cytostatic regimen in patients with advanced colorectal cancer.
Topics: Adult; Aged; Antidotes; Antimetabolites, Antineoplastic; Colonic Neoplasms; Disease Progression; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Prospective Studies; Rectal Neoplasms; Recurrence; Remission Induction | 1998 |
High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Protocols; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Mastectomy, Modified Radical; Middle Aged; Radiotherapy, Adjuvant; Recurrence; Survival Rate | 1998 |
[Implantation of controlled-release 5-FU for the prevention of secondary cataract: preliminary study].
Topics: Animals; Antimetabolites; Cataract; Cataract Extraction; Delayed-Action Preparations; Fluorouracil; Rabbits; Recurrence | 1998 |
Comparative analysis of breast cancer recurrence risk for patients receiving or not receiving adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF). Data supporting the occurrence of 'cures'.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Incidence; Logistic Models; Mastectomy, Radical; Methotrexate; Recurrence; Retrospective Studies; Risk Assessment; Survival Analysis; Survival Rate; Time Factors | 1999 |
Pan-urethral warts as a cause of acute retention of urine.
Topics: Adult; Antimetabolites, Antineoplastic; Condylomata Acuminata; Fluorouracil; Humans; Male; Recurrence; Urethral Diseases; Urinary Retention | 1999 |
The effect of 5-fluorouracil on Dupuytren fibroblast proliferation and differentiation.
Topics: Aged; Antimetabolites; Case-Control Studies; Cell Count; Cell Differentiation; Cell Division; Cells, Cultured; Chemotherapy, Adjuvant; Drug Evaluation, Preclinical; Dupuytren Contracture; Female; Fibroblasts; Fluorouracil; Humans; Male; Middle Aged; Myofibrils; Recurrence | 2000 |
The effect of nodal status on determinants of initial treatment response and patterns of relapse-free survival in nasopharyngeal carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Multivariate Analysis; Nasopharyngeal Neoplasms; Neoplasm Staging; Radiotherapy Dosage; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome | 2000 |
Adjuvant chemotherapy for stage II colon cancer: the time has come.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Fluorouracil; Humans; Levamisole; Neoplasm Staging; Prognosis; Randomized Controlled Trials as Topic; Recurrence | 2000 |
Recurrent endogenous candidal endophthalmitis in a premature infant.
Topics: Amphotericin B; Betaxolol; Candida albicans; Candidiasis; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Fluorouracil; Humans; Infant, Newborn; Infant, Premature; Lens, Crystalline; Microbial Sensitivity Tests; Prednisolone; Recurrence; Vitrectomy; Vitreous Body | 2001 |
[A patient with obstructive jaundice due to recurrence after gastric cancer surgery responding remarkably to FLP combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cholestasis; Cisplatin; Drainage; Drug Administration Schedule; Fluorouracil; Gastrectomy; Humans; Leucovorin; Lymph Nodes; Lymphatic Metastasis; Male; Recurrence; Stomach Neoplasms | 2001 |
Thalidomide for recurrent renal-cell cancer in a 40-year-old man.
Topics: Adenocarcinoma, Clear Cell; Adult; Angiogenesis Inhibitors; Carcinoma, Renal Cell; Drug Therapy, Combination; Fluorouracil; Humans; Interleukin-2; Kidney Neoplasms; Male; Neoplasm Metastasis; Pilot Projects; Recurrence; Thalidomide | 2000 |
CEA and CA 19-9 measurement as a monitoring parameter in metastatic colorectal cancer (CRC) under palliative first-line chemotherapy with weekly 24-hour infusion of high-dose 5-fluorouracil (5-FU) and folinic acid (FA).
Topics: Adult; Aged; Antimetabolites, Antineoplastic; CA-19-9 Antigen; Carcinoembryonic Antigen; Colorectal Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Male; Middle Aged; Palliative Care; Recurrence; Sensitivity and Specificity | 2001 |
Treatment side effects. Case 3. Fluorouracil-induced exacerbation of systemic lupus erythematosus.
Topics: Acute Disease; Antimetabolites, Antineoplastic; Fluorouracil; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Recurrence | 2002 |
The role of chemotherapy in the management of cancer of the head and neck: a review.
Topics: Bleomycin; Dinitrochlorobenzene; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Head and Neck Neoplasms; Humans; Immunotherapy; Infusions, Parenteral; Injections, Intra-Arterial; Leucovorin; Methotrexate; Mouth Neoplasms; Recurrence | 1975 |
Ovarian function and adjuvant chemotherapy for breast cancer.
Topics: Adult; Age Factors; Aged; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Melphalan; Middle Aged; Ovary; Prednisone; Recurrence | 1978 |
Chemotherapy in bladder carcinoma.
Topics: Antineoplastic Agents; Bleomycin; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Humans; Recurrence; Thiotepa; Urinary Bladder Neoplasms; Vincristine | 1978 |
Combined chemoimmunotherapy and radiation therapy of inflammatory breast carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; BCG Vaccine; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Middle Aged; Radiotherapy, High-Energy; Recurrence; Remission, Spontaneous; Time Factors | 1979 |
BCNU-5-fluorouracil combination therapy for recurrent malignant brain tumors.
Topics: Astrocytoma; Bone Marrow; Brain Neoplasms; Carmustine; Drug Therapy, Combination; Fluorouracil; Glioblastoma; Glioma; Humans; Procarbazine; Recurrence; Remission, Spontaneous | 1978 |
Adjuvant chemo-immuno-therapy with LMF+BCG in node-negeative and node-positive breast cancer.
Topics: Antineoplastic Agents; BCG Vaccine; Breast Neoplasms; Chlorambucil; Drug Therapy, Combination; Female; Fluorouracil; Humans; Immunotherapy; Mastectomy; Methotrexate; Mycobacterium bovis; Prednisone; Recurrence | 1978 |
Lack of effectiveness of combined 5- fluorouracil and methyl-CCNU therapy in advanced colorectal cancer.
Topics: Carcinoembryonic Antigen; Colonic Neoplasms; Drug Therapy, Combination; Female; Fluorouracil; Humans; Male; Nitrosourea Compounds; Rectal Neoplasms; Recurrence; Semustine | 1977 |
Intensive postoperative chemoimmunotherapy for patients with stage II and stage III breast cancer.
Topics: Adult; Aged; BCG Vaccine; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Fluorouracil; Follow-Up Studies; Humans; Immunotherapy; Male; Middle Aged; Neoplasm Staging; Recurrence | 1978 |
Quadruple chemotherapy in the treatment of advanced or recurrent gastrointestinal carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Male; Methotrexate; Middle Aged; Recurrence; Remission, Spontaneous; Time Factors; Vincristine | 1977 |
Selection of chemotherapy for metastatic mammary cancer by effect on cesium-131 uptake.
Topics: Antineoplastic Agents; Breast Neoplasms; Cesium; Cesium Radioisotopes; Cyclophosphamide; Diethylstilbestrol; Drug Therapy, Combination; Female; Fluorouracil; Humans; Neoplasm Metastasis; Radionuclide Imaging; Receptors, Estrogen; Recurrence; Remission, Spontaneous | 1977 |
Treatment of solar keratoses with a 5-fluorouracil and salicylic acid varnish.
Topics: Administration, Topical; Adult; Aged; Collodion; Drug Combinations; Female; Fluorouracil; Hand; Humans; Keratosis; Male; Middle Aged; Paint; Recurrence; Salicylates; Sunlight | 1975 |
Combination chemotherapy as an adjuvant treatment in operable breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Recurrence; Time Factors | 1976 |
Effect of antineoplastic agents on smooth muscle cell proliferation in vitro: implications for prevention of restenosis after transluminal angioplasty.
Topics: Angioplasty, Balloon; Animals; Antineoplastic Agents; Cell Division; Cells, Cultured; Constriction, Pathologic; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Fluorouracil; Muscle, Smooth, Vascular; Pulmonary Artery; Recurrence; Swine | 1992 |
5-fluorouracil cardiotoxicity: the risk of rechallenge.
Topics: Angina Pectoris; Coronary Vasospasm; Fluorouracil; Humans; Myocardial Infarction; Recurrence | 1991 |
Weight gain with breast cancer adjuvant treatment.
Topics: Adaptation, Psychological; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Melphalan; Methotrexate; Middle Aged; Prednisone; Recurrence; Regression Analysis; Social Support; Vinblastine; Weight Gain | 1991 |
Cancer chemotherapy: hormonal changes and recurring asthma.
Topics: Adenocarcinoma; Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Asthma; Breast Neoplasms; Cyclophosphamide; Drug Hypersensitivity; Female; Fluorouracil; Humans; Methotrexate; Recurrence | 1991 |
Genital human papillomavirus infection in men. Diagnosis and treatment with a laser and 5-fluorouracil.
Topics: Acetates; Acetic Acid; Administration, Topical; Adult; Colposcopy; Combined Modality Therapy; Condylomata Acuminata; Fluorouracil; Genital Neoplasms, Male; Humans; Laser Therapy; Male; Middle Aged; Recurrence; Sexual Partners | 1991 |
[Myocardial infarcts within the scope of 5-fluorouracil therapy].
Topics: Adenocarcinoma; Adult; Electrocardiography; Fluorouracil; Humans; Infusions, Intravenous; Liver Neoplasms; Male; Myocardial Infarction; Pancreatic Neoplasms; Recurrence | 1990 |
Long-term followup of subclinical human papillomavirus infection treated with the carbon dioxide laser and intraurethral 5-fluorouracil: a treatment protocol.
Topics: Combined Modality Therapy; Fluorouracil; Humans; Laser Therapy; Male; Papillomaviridae; Penile Diseases; Recurrence; Tumor Virus Infections | 1990 |
Phase I study of a 120-hour continuous intravenous infusion of 5-fluorouracil in pediatric patients with recurrent solid tumors: a Pediatric Oncology Group study.
Topics: Adolescent; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Fluorouracil; Gastrointestinal Diseases; Hematologic Diseases; Humans; Infusions, Intravenous; Neoplasms; Recurrence | 1990 |
Adjuvant chemotherapy and scar irradiation in breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Prednisone; Prospective Studies; Recurrence; Survival Rate | 1990 |
Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy; Menopause; Methotrexate; Recurrence | 1990 |
Multicentric reticulohistiocytosis and cancer: a case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arthritis; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cyclophosphamide; Female; Fluorouracil; Histiocytes; Humans; Lymphatic Diseases; Lymphatic Metastasis; Methotrexate; Middle Aged; Paraneoplastic Syndromes; Prednisone; Recurrence; Skin Diseases; Staining and Labeling | 1985 |
5-Fluorouracil (5-Fu) in the treatment of prostatic hyperplasia.
Topics: Adult; Aged; Aged, 80 and over; Fluorouracil; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Recurrence; Urinary Incontinence | 1987 |
Keratoacanthomas treated with Mohs' micrographic surgery (chemosurgery). A review of forty-three cases.
Topics: Aged; Aged, 80 and over; Female; Fluorouracil; Humans; Keratoacanthoma; Male; Microsurgery; Middle Aged; Postoperative Care; Recurrence; Skin Diseases; Staining and Labeling | 1987 |
[Amoebic dysentery: a relapsing case by cancer chemotherapy].
Topics: Aged; Carcinoma, Squamous Cell; Dysentery, Amebic; Fluorouracil; Humans; Immune Tolerance; Immunity, Cellular; Male; Opportunistic Infections; Recurrence; Tonsillar Neoplasms | 1989 |
Sexually transmitted papillomaviral infections: V. Prophylactic use of topical 5-fluorouracil in refractory infection in the male.
Topics: Administration, Topical; Drug Evaluation; Fluorouracil; Follow-Up Studies; Humans; Male; Papillomaviridae; Penile Diseases; Recurrence; Sexual Partners; Sexually Transmitted Diseases; Tumor Virus Infections | 1989 |
The clinical syndrome of 5-fluorouracil cardiotoxicity.
Topics: Adult; Aged; Coronary Disease; Death, Sudden; Electrocardiography; Female; Fluorouracil; Heart Diseases; Humans; Male; Middle Aged; Myocardial Infarction; Recurrence | 1989 |
Adenocarcinoma of the ethmoid sinuses. Results of a new protocol based on inductive chemotherapy combined with surgery. Four years experience.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Ethmoid Sinus; Female; Fluorouracil; Humans; Male; Middle Aged; Paranasal Sinus Neoplasms; Recurrence | 1989 |
Sexually transmitted papillomaviral infections: III. Management of male partner.
Topics: Adolescent; Adult; Combined Modality Therapy; Electrocoagulation; Female; Fluorouracil; Follow-Up Studies; Genital Diseases, Male; Humans; Laser Therapy; Male; Middle Aged; Papillomaviridae; Recurrence; Sexually Transmitted Diseases; Tumor Virus Infections | 1988 |
Management of human papillomavirus-associated genital lesions in men.
Topics: Adolescent; Adult; Combined Modality Therapy; Condylomata Acuminata; Cryosurgery; Fluorouracil; Genital Diseases, Male; Genital Neoplasms, Male; Humans; Laser Therapy; Male; Middle Aged; Neoplasm Recurrence, Local; Recurrence; Sexually Transmitted Diseases, Viral; Tumor Virus Infections | 1989 |
Comments on primary and adjuvant treatments of breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymph Node Excision; Lymphatic Metastasis; Methotrexate; Prognosis; Recurrence | 1988 |
[Intra-arterial continuous infusion in patients with advanced and recurrent cancer of the digestive system].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Colonic Neoplasms; Doxorubicin; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Infant; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Pancreatic Neoplasms; Prognosis; Recurrence | 1985 |
Treatment of diffuse aggressive non-Hodgkin's lymphomas with an intensive multi-drug regimen including high-dose cytosine arabinoside (F-MACHOP).
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Recurrence; Vincristine | 1985 |
[Hormone therapy and chemotherapy of metastasizing breast cancer. Experiences of the Basle Oncology Center, 1969-72].
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma; Castration; Cyclophosphamide; Drug Therapy, Combination; Estradiol; Estrogens; Ethinyl Estradiol; Female; Fluorouracil; Hormones; Humans; Hypophysectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Ovary; Prednisone; Recurrence; Remission, Spontaneous; Vincristine | 1974 |
Fluorouracil ointment treatment of porokeratosis of Mibelli.
Topics: Adult; Dermatitis, Contact; Female; Fluorouracil; Humans; Keratosis; Male; Middle Aged; Ointments; Recurrence | 1973 |
[Postoperative chemotherapy as means of prophylaxis of recurrences and metastases of cancer of the rectum].
Topics: Aged; Female; Fluorouracil; Humans; Injections, Intravenous; Neoplasm Metastasis; Neoplastic Cells, Circulating; Postoperative Care; Rectal Neoplasms; Recurrence; Remission, Spontaneous | 1973 |
Topically administered fluorouracil in psoriasis.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Epithelial Cells; Female; Fluorouracil; Humans; Male; Middle Aged; Occlusive Dressings; Ointments; Psoriasis; Recurrence; Time Factors | 1972 |
[Treatment of skin cancer].
Topics: Age Factors; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Lip Neoplasms; Male; Melanoma; Prognosis; Recurrence; Skin Neoplasms | 1971 |